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an α-
Abstract 
The bacteriocin plantaricin J/K consists of the two peptides PlnJ and PlnK, and the 
two peptides must be present for optimal bacteriocin function. In this study, the three 
dimensional structure of the PlnJ peptide was determined by use of NMR 
spectroscopy. 15N labelled PlnJ for structure determination was produced by 
Escherichia coli BL-21. A pGEV-2 vector, containing a gene encoding a fusion of 
the immunoglobulin binding domain of Streptococcal protein G (GB1 domain) and 
PlnJ, was used to transform the bacteria. Peptide production was achieved by 
inducing expression of the gene in 15N enriched minimal media (M9). The PlnJ target 
peptide was cleaved from the GB1 domain fusion partner with cyanogen bromide, 
and purified using reverse phase HPLC. Molecular weight was determined to be 
2970, using a MALDI-TOF mass spectrometer, indicating a 99 % degree of 15N 
labeling. The produced PlnJ was found to be biologically active when mixed with 
equimolar amounts of synthetic PlnK prior to being exposed to cells sensitive to 
plantaricin J/K. Structural investigations of PlnJ were made using circular dichroism 
(CD) spectroscopy and NMR spectroscopy. Structuring was calculated from CD data 
using the absorbance at 222 nm as a quantitative measure of α-helical content, and by 
fitting the entire spectrum to the CD spectra of a data base using the CDPro software 
package. Structural constraints were obtained by analyzing NMR spectra: NOE 
distance constraints from a NOESY-HSQC spectrum and a NOESY spectrum, 
dihedral angle constraints calculated from the 3JHNHα found in a HNHα spectrum, φ 
and ψ torsion angle constraints obtained by matching chemical shifts to a data base 
using the TALOS software. These constraints were used to calculate a three 
dimensional structure using the CYANA software. All structural data supports 
helical structure. Furthermore, the data suggests that the helical content is divided 
between two regions spanning amino acid residues 3-13 and 18-21 and that the 
molecule is linear. The side chains of the polar and the non polar amino acid residues 
of PlnJ are confined to separate sides of the long axis of the structure, making it an 
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1. Introduction 
1.1 Antimicrobial peptides 
Antimicrobial peptides, AMP’s, are a divers group of molecules that inhibit the 
growth of micro organisms. Numerous bacterial strains and species of mammals, 
amphibians, birds, insects and plants synthesize these substances. AMP’s kill micro 
organisms that are pathogenic to, or compete with, the producing organism and may 
thus be considered evolutionary adaptations [1-4].  
1.2 Bacteriocins      
The term bacteriocin first described antimicrobial substances secreted by bacteria [5]. 
A later paper specified that a bacteriocin had to be of proteinaceous nature and kill 
bacteria closely related to the bacteriocin producing species [6]. Currently, any 
ribosomally synthesized AMP from bacteria is termed a bacteriocin [7] 
Although in some ways similar to conventional antibiotics, bacteriocins differ from 
these in that they are ribosomally synthesized. Their target specificity is much 
narrower, and to each bacteriocin system there is associated a protein conveying 
immunity. Bacteriocins are produced during the exponential phase of the bacteria’s 
growth while antibiotics are synthesized during the stationary phase [8, 9]. 
In many of the bacterial species investigated, there have been found bacteriocins [6, 
10]. The bacteriocins produced by lactic acid bacteria (LAB) and E. coli are the ones 
that are best characterized, biochemically as well as genetically and structurally.  The 
LAB bacteriocin nisin (Lactococcus lactis) has for the past 50 years been used as a 
food preservative [9]. LAB naturally occur in food consumed by mammals, they are, 
as their bacteriocins, non pathogenic, and compete with pathogenic and food spoiling 
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bacteria. The great interest in LAB bacteriocins is largely due to their potential for 
use as food preservatives and in treatment of disease [9, 11].  
1.3 Classification of LAB bacteriocins 
LAB bacteriocins may be divided into three classes based on their size, the presence 
or absence of modified amino acid residues and heat stability [8]. 
 Class I- Small (<10kD), posttranslationally modified polypeptides that contain 
the modified amino acid residues lanthionine and/or methyllanthionine. These 
bacteriocins are often termed lantibiotics. 
 Class II- Small (<10kD), polypeptides that do not contain modified amino acid 
residues. 
 Class III- Large (relative to other bacteriocins) (>10kD), heat labile 
polypeptides. 
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The unmodified class-II peptide bacteriocins are further divided into three 
subclasses:
 
Figure 1 Classification of bacteriocins and sub-classification of the class II 
bacteriocins.  
1.3.1 Class-IIa 
The pediocine-like peptides are grouped together because of their sequence 
similarity, and take their name from pediocin PA-1, the first of the group to be 
described. All the class-IIa bacteriocins have a conserved YGNGV motif in the N-
terminal half [12]. In addition to the conserved motif, the bacteriocins in this subclass 
show extended sequence similarities, particularly in the N-terminal part, as well as 
3D structural similarities. The general structure of the pediocin-like bacteriocins 
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consists of an N-terminal β-sheet-like structure and a C-terminal helix-containing 
structure, linked by a hinge region [13].   
1.3.2 Class-IIc  
Class-IIc consists of a divers group of one-peptide bacteriocins that do not share 
sequence similarities with pediocin PA-1. Further subdivisions have been suggested 
for this class [14]. 
1.3.3 Class-IIb 
Class-IIb consists of the two-peptide bacteriocins, all of which contain two 
synergistically functioning peptides that are cationic at neutral pH and contain 
hydrophobic and/or amphiphillic regions [15]. Both peptide components of the two-
peptide bacteriocins must be present for optimum activity, as the individual peptides 
have little, if any, bacteriocidal activity [16]. The simultaneous and equimolar 
secretion of each of the peptides is also important to assure maximum bactericidal 
effect, and, at optimal conditions, the two-peptide bacteriocins display at least a 
thousand fold higher activity than each of the peptides separately [15].  As elaborated 
below, it has been shown that both peptides of all class-IIb bacteriocins are 
transcribed from genes positioned next to each other within the same transcriptional 
unit, and that there is only one immunity protein per class-IIb bacteriocin. In addition, 
it has been documented that two-peptide bacteriocins are in physical contact while 
performing their antimicrobial function [17, 18]. This indicates that the two peptides 
of two-peptide bacteriocins function as one antimicrobial unit, and are not simply two 
synergistically acting one-peptide bacteriocins. Below is a table of two-peptide 
bacteriocins.  
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Table 1 Sequences of known two-peptide bacteriocins. GXXXG motif are 
marked by the bold case. Note that the β peptides of plantaricin S and NC8 
lack the GXXXG motif, but have similar AXXXA (pls β) or SXXXS(pln NC8). 
Sequences from [19]   
Bacteriocin Sequence 
Lactococcin G Lcnα:  
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRI 
NRKKKH 
Lcnβ: 
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWK NI 
Lactococcin Q α: 
SIWGDIGQGVGKAAYWVGKANGNMSDVNQASRI 
NRKKKH 
β: 
KKWGNLAWVEPAGEFLKGFGKGAIKEGNKDKWK NI 
Plantaricin 
E/F 
E: 
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR 
F: 
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG 
Plantaricin 
J/K 
J: 
GAWKNFWSSLRKGFYDGEAGRAIRR 
K: 
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK 
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Plantaricin S α: 
RNKLAYNMGHYAGKATIFGLAAWALLA 
β: 
KKKKQSWYAAAGDAIVSFGEGFLNAW 
Plantaricin 
NC8 
α: 
DLTTKLWSSWGYYLGKKARWNLKHPYVQF 
β: 
SVPTSVYTLGIKILWSAYKHRKTIEKSFFNKGFYH 
Lactacin F A: 
RNNWQTNVGGAVGSAMIGATVGGTICGPACAVA 
GAHYLPILWTGVTAATGGFGKIRK 
X: 
NRWGDTVLSAASGAGTGIKACKSFGPWGMAICG 
VGGAAIGGYFGYTHN 
Brochocin-C A: 
YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIP 
GAFVGAHFGVIGGSAACIGGLLGN 
B: 
KINWGNVGGSCVGGAVIGGALGGLGGAGGGCITG 
AIGSIWDQW 
Thermophilin 
13 
A: 
YSGKDCLKDMGGYALAGAGSGALWGAPAGGVG 
ALPGAFVGAHVGAIAGGGFACMGGMIGNKFM 
B: 
QINWGSVVGHCIGGAIIGGAFSGGAAAGVGCLVGS 
GKAIINGL 
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ABP-118  Abp118α: 
KRGPNCVGNFLGGLFAGLAAAGVPLGPAGIVGGA 
NLGMVGGALTCL 
Abp118β: 
KNGYGGSGNRWVHGGAGIVGGALIGAIGGPWSAV 
AGGISGGFTSCR 
Salvaricin P Sln1: 
KRGPCNVGNFLGGLFAGAAAGVPLGPAGIVGGANL 
GMVGGALTCL 
Sln2: 
KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVA 
GGISGGFASCH 
Mutacin IV NlmA: 
KVSGGEAVAAIGICATASAAIGGLAGATLVTPYSVG 
TWGLIRSH 
NlmB: 
DKQAADTFLSAVGGAASGFTYCASNGVWHPYILA 
GCAGVGAVGSVVFPH 
Lactocin 705 705α: 
GSMGIYQGIPDFLKGYLHGISAANKHKKGRLGY 
705β: 
GFWGGLGYIAGRVGAAYGHAQASANNHHSPING 
Enterocin 
1071 
A: 
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRI NRKKH 
B: 
GPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWK NV 
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1.4 Genetics and expression of class-IIb bacteriocins 
In general, five genes are needed for the expression of two-peptide bacteriocins; two 
structural genes encoding the bacteriocin itself, a gene encoding an immunity protein, 
a gene encoding a dedicated ABC-transporter and one encoding an accessory protein 
of unknown function, but which is important for secretion [10, 20, 21]. The structural 
genes are found next to each other on the same operon, ensuring that equal amounts 
of the two are produced. The gene for the immunity protein is found on the same 
operon [16]. All two-peptide bacteriocins are transcribed as inactive preforms 
containing an N-terminal 15-30 residue double-glycine leader [16]. Upon export, this 
leader sequence is cleaved off at the C-terminal end of the double-glycine motif, thus 
activating the bacteriocin [16]. Distinguishing the dedicated bacteriocin ABC-
transporter from other ABC-transporters is a 150 residue N-terminal extension [22]. 
Studies on the lactococcin G two-peptide bacteriocin and its ABC transporter 
revealed that the N-terminal extension cleaved off the leader sequence of the 
bacteriocin [22]  
1.5 Immunity 
Immunity against the bacteriocin is conveyed by a protein transcribed from the same 
operon as the bacteriocin itself. Putative immunity protein genes have for the most 
part been confirmed as such upon rendering cells, into which the genes have been 
transferred, insensitive to their cognate bacteriocin [23-29]. It has not been clarified 
exactly how the immunity proteins confer resistance to bacteriocins, but studies show 
that the proteins have to be expressed by the cell, simply adding immunity protein to 
a cell culture will not deter bacteriocin activity [27]. Even though the class-IIb 
bacteriocins consist of two peptides, they each have only one immunity protein 
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1.6 Control of expression  
Expression of some of the two-peptide bacteriocins is controlled by a three-
component quorum sensing regulatory pathway [30-38]. The components of this 
pathway are a peptide pheromone, a membrane associated histidine protein kinase 
and response regulators [39, 40]. Quorum sensing is a cell density sensing system: a 
low constitutive expression of a peptide pheromone, plnA in the LAB strain L. 
plantarum, leads to increasing pheromone concentration as cell density increases. 
When the pheromone concentration reaches a threshold value, the histidine protein 
kinase is triggered to phophorylate two response regulators, which in turn activate 
genes involved in bacteriocin production [32-37] 
1.7 Structure of two-peptide bacteriocins 
Circular dichroism (CD) studies combined with Edmundson α-helical wheel 
sequence displays reveal that a common structural feature of some two-peptide 
bacteriocins is an amphiphilic α-helix [16]. The structuring of the peptides required 
the presence of a structure inducing agent, such as tetrafluoroethanol (TFE), or a 
membrane mimicking entity like dodecylphosphocholine (DPC) micelles. It was also 
shown that further structuring was achieved upon equimolar and simultaneous 
addition of the two peptides of two-peptide bacteriocins to the membrane mimicking 
entities, and it thus appears that the two peptides of two-peptide bacteriocins interact 
in a structuring manner when exerting their bactericidal effect [16]. 
Another suggested secondary structure element of two-peptide bacteriocins is a 
hydrophobic β-sheet either with or without a cystein residue at each end of the 
primary structure [41]. 
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A reoccurring sequence motif in many, if not all, two-peptide bacteriocins is a 
GXXXG (AXXXA and SXXXS also occur) sequence within a stretch that may form 
an α-helix, see Table 1. The additional structuring seen in two-peptide bacteriocins 
upon interaction of their two peptides with membranes, is thought to be mediated by 
the GXXXG motifs since it has been shown that these motifs are involved in helix-
helix interactions [42]. Mutational studies have shown that substituting the glycines 
in some of these motifs with more bulky amino acid residues is detrimental to the 
activity of the two-peptide bacteriocins enterocin 1071 and lactococcin G [43], 
indicating that the glycines facilitate close contact. 
For lactococcin G, a structure has been proposed in which the α and β peptides are 
connected through the GXXXG motifs of residues 7-11 (α) and 18-22 (β), and the 
two peptides form a coil-coil and lay in a parallel yet staggered way relative to each 
other [44]. In this proposed structure, the GXXXG motif of the α-peptide lies in an α-
helix spanning residues 3-21, whereas the β-peptide GXXXG motif lies at the end of 
an α-helix spanning residues 6-19 [44]. There are C-terminal helixes in both peptides, 
residues 24-34 in the α-peptide and residues 23-32 in the β-peptide. The C-terminal 
helix of the β-peptide was only observed when TFE was used as structuring agent, 
and the above proposed GXXXG interacting structure could cause structuring of 
residues 18-21 and stabilization of the C-terminal helix of the β-peptide. This would 
lead to a continuous helix-helix structure running from the N-terminus to residue 24 
in the α-peptide, and from residue 12-35 in the β-peptide [44]. It is further suggested 
that this might be a general structure for a group of three homologous two-peptide 
bacteriocins; lactococcin G, lactococcin Q and enterocin 1071 [44]. The suggested 
structure accounts for the enhanced helix formation upon α-β interaction reported by 
Hauge et.al. [17]. 
NMR studies of the plantaricin E/F two-peptide bacteriocin reveal that its two 
peptides both adopt amphiphilic α-helical structures in the presence of DPC micelles. 
In PlnE, there is a kink at proline 20, whereas for PlnF the helical structure is 
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interrupted by a more flexible region at amino acid residues 21-24. In both peptides 
the N-terminal region is both more polar and less structured [45].   
1.8 Mode of action 
All two-peptide bacteriocins, whose mode of action has been analyzed, render the 
membrane of target cells permeable to small monovalent molecules and thus disturb 
vital transmembrane concentration differences. Insight as to how ion conducting 
pores are made is still lacking, but the fact that membrane-mimicking substances 
induce structuring in bacteriocins indicates a membrane-interacting mode of action 
[16].  
Of the two-peptide bacteriocins who’s mode of action has been investigated, there 
has been shown to be a difference in ion specificity of the pores formed in the 
membrane of target cells [16]. This specificity, combined with additional structuring 
of the bacteriocins upon membrane interaction and the low peptide concentration 
needed for activity, leads to the conclusion that a general destabilization of target cell 
membranes as a result of  peptide interaction is not plausible [16].  
A membrane spanning target cell interaction has been suggested for lactococcin G: a 
cluster of positively charged amino acid residues at the C-terminus is thought to be 
driven through the membrane by the transmembrane potential (negative on the 
inside), leaving the double helix inside the membrane and the N-terminus outside or 
in the inter phase of the membrane [44]. 
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1.9 Plantaricin J/K 
Table 2 Amino acid sequence of plantaricin J/K, one-letter code. GXXXG 
motif in bold.  
  
PlnJ GAWKNFWSSLRKGFYDGEAGRAIRR 
PlnK RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK 
 
Table 2 shows the amino acid sequence of plantaricin J/K.  
The molecular mass of plantaricin J (PlnJ) is 2929 Da, and that of plantaricin K 
(PlnK) is 3503 Da. 
Plantaricin J/K is one of several peptide bacteriocins produced by Lactobacillus 
plantarum C11, all of them referred to as plantaricins. Investigations show that there 
seems to be a total of five operons involved in the production of mature bacteriocin in 
L. plantarum C11: plnABCD, plnEFI, plnJKLR, plnMNOP and plnGHSTUV [31]. 
The secreted peptide product, Pln A, of the A gene on the ABCD operon is the 
peptide pheromone that induces both transcription of the ABCD locus and 
bacteriocin production [32]. The plnB gene encodes a histidine kinase, which together 
with two antagonistic response regulators, encoded by the plnC and plnD genes, 
effect the transcription of genes induced by PlnA [34]. Of the remaining four 
operons, three contain ORF’s for bacteriocins, PlnEF, PlnJK and PlnN. PlnEF and 
PlnJK are two-peptide bacteriocins, whereas PlnN is a one-peptide bacteriocin. 
Included on the operon with each of these bacteriocins are the genes encoding their 
corresponding immunity proteins: PlnI, PlnL and PlnM/P respectively [31]. The forth 
operon, plnGHSTUV, contains the GH ORF encoding an ABC transporter, PlnG, and 
its accessory protein, PlnH [31].  
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1.10 Aim of study 
The aim of this study is to determine the three dimensional structure of the plantaricin 
J peptide-component of the plantaricin J/K two-peptide bacteriocin by NMR 
spectroscopy. In order to accommodate 15N edited NMR techniques, a 15N marked 
peptide will be produced by over-expression in E. coli using 15N enriched media. 
Before NMR spectroscopic investigation of the peptide, it will be purified using 
HPLC, molecular weight will be determined by MALDI-TOF mass spectroscopy, 
and biological activity will be verified through a bacteriocin assay.     
Structure determination is the key to understanding how a bacteriocin exerts its 
function. Primary structure, secondary structure and the orientation of secondary 
structure elements relative to one another provide a topographic map of the peptide, 
which is important in understanding how the bacteriocin interacts with the target cell 
membrane when forming ion specific pores.  
As mentioned in section 1.7, it has been shown that the two peptides of two-peptide 
bacteriocins are in contact when exerting their bacteriocin activity and that further 
structuring is achieved when the two peptides make contact. The determinations of 
the individual structures are therefore necessary steps to elucidate the structure-
function relationship of plantaricin J/K. 
Bacteriocins are unstructured in water, but gain structure as they make contact with 
the membrane of the target cell. In order to induce structuring of the peptide, DPC 
micelles serve as a membrane mimicking entities [46]. 
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2. A brief description of some methods used in 
this thesis  
2.1 Circular Dichroism (CD) spectroscopy 
Due to the different extinction coefficients optically active samples have for left and 
right circularly polarized light, absorption produces elliptically polarized light. A 
circular dichroism spectrum is a display of either the per residue difference in 
extinction coefficient, for right and left circularly polarized light, Δε, or the per 
residue elipticity, θ, as a function of wavelength [47].  
θ is defined as  
LR
LR
EE
EE

tan  
Formula 1 
where ER and EL are the electric field vector magnitudes of right and left circularly 
polarized light, respectively [47]. This is further illustrated by the figure below: 
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Figure 2 Unequal contributions of right (red)- and left(blue)- circularly 
polarized light creates elliptically polarized light of θ degrees. Figure from 
Wikipedia.  
There is a simple proportional relationship between these sizes as they both can be 
used to calculate the difference in absorption of right and left polarized light, ΔA; 
32982/  Acl  
Formula 2 
where c is concentration and l is the length of the light path. Chiral centers in amino 
acids give proteins an intrinsic optical activity, but  more interesting is the fact that 
the asymmetry of the α-helix contributes to this activity, thus making it possible to 
calculate helical content by CD spectroscopy [47]. 
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Figure 3 below shows the signature CD spectra of an α-helix, a β-sheet and a random 
coil protein. 
 
Figure 3 Signature CD spectra of α-helix, black, β-sheet, red, and random 
coil protein, green. Figure from www.ap-lab.com/circular_dichroism.htm 
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2.2 Nuclear Magnetic Resonance spectroscopy 
2.2.1 Basics 
NMR active nuclei possess a property called spin angular momentum, I. It is 
characterized by the spin angular momentum quantum number, I, called the spin of 
the nucleus, which can take integer or half integer values ≥ 0 [48].  
This thesis will only consider spin ½ nuclei.  
In a Cartesian coordinate system, the z component of I, Iz, has a value specified by 
the magnetic quantum number, m:  
mI z   
Formula 3 
where ħ is Plancks constant divided by 2π [48].  
For spin ½ nuclei there are two possible states for Iz; 1/2ħ and -1/2ħ, these are 
referred to as the α and β state, respectively [48]. 
Aligned with I (when I > 0) is a nuclear magnetic moment, µ. The z component of µ, 
µz, has a value which is a function of Iz and the magnetogyric ratio, γ, intrinsic to 
each nucleus [48]:  
 zz I  
Formula 4 
The quantization of Iz leads to quantization of µz [48]. 
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When a system of spins is placed in a static magnetic field, B0, the magnetic nature of 
µz leads to non-degeneracy of the two Iz states α and β.  The energy difference 
between the α and β states is proportional to both the static magnetic field and γ. The 
sign of gamma determines which of the states is the low energy one [48].  
0BE   
Formula 5 
The energy difference leads to a difference in the population of the two states. The 
fraction of the population of the two states, Nα/Nβ, is described by the Boltzman 
distribution: 
kTEeNN //   
Formula 6 
where k is the Boltzman constant and T is the absolute temperature [48]. The 
difference in population leads to an accumulation of the z-components of the 
magnetic moments along or against (positive and negative γ respectively) the static 
magnetic field. Since the value of Iz is less than the value of I, it follows that µ is not 
aligned with B0, but the x and y components of µ are non-coherent and sum to zero 
[48].  This results in a net magnetization vector M, aligned with the static magnetic 
field [48]. The rotating frame of reference, a Cartesian coordinate system rotating 
with the same frequency as the Larmour frequency of the observed spin is defined as 
having its +z-axis pointing in the same direction as M. Figure 4 illustrates the net 
magnetization vector. 
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Figure 4 Illustration of net magnetization vector, M. Blue arrows are 
individual spin magnetization vectors, each having x-,y- and z-components. 
Grey arrows are net magnetization vectors for all axes. All net 
magnetization vectors, except the one in +z direction, have counterparts 
pointing in the opposite direction. This means that the effect of all 
magnetization, except +z magnetization, is canceled by magnetization 
pointing in the opposite direction.  
The static magnetic field imposes a torque on µ, causing it to precess about the 
direction of the static magnetic field, which coincides with the z-axis [48]. 
The rate with which µ precesses is proportional to the energy difference between the 
two Iz states [48]: 
E  
Formula 7 
 2/B0  
Formula 8 
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This is the Larmour frequency of the spin.  
The γ-values describe the magnetic strength of the nuclei [49]. Below is a table of 
important NMR active nuclei, their natural abundance and γ values. 
Table 3 The magnetogyric ratio and natural abundance of some interesting 
spin 1/2 nuclei 
 
Nuclei 
 
Magnetogyric ratio 
107radT-1s-1 
 
Natural abundance 
% 
1H 26.75 99.98 
13C 6.728 9.11 
15N -2.713 0.37 
31P 10.83 100 
19F 25.18 100 
 
In the following, a spin refers to the magnetic moment associated with spin ½ nuclei. 
2.2.2 Chemical shift 
Local secondary magnetic fields, arising from motion in the local electron density 
induced by the static magnetic field, alters the perceived static field, Blocal, for all 
spins. It is said that local magnetic fields either shield or deshield spins from the 
effect of the static magnetic field. For isotropically tumbling molecules, this 
shielding/deshielding is described by adding a modifying term to the function for the 
Larmor precession of spins. The modifying term contains σ, which is an average 
isotropic shielding constant for each spin [48]. 
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0)1(2/ B   
Formula 9 
Positive σ describes a shielding effect in which the spin in question perceives a 
weaker magnetic field and hence precesses at a lower frequency. The shielding is 
caused by local magnetic fields opposing the static field [48]. This shift in resonant 
frequency due to a chemical environment is called the chemical shift of spins. 
In proteins/peptides, the resonant frequency of spins varies in a predictable manner 
depending on their position in an amino acid and the structure of the protein/peptide 
(see 2.2.4) [50-52]. 
 
Figure 5 The amino acid arginine in a peptide bond with amino acids   N-1 
and N+1. The atoms of the side chain are named with Greek letters 
according to their distance from the backbone. Not apparent from this figure 
is the geometry about the central Cα, see 3.8.5. Nomenclature in the figure 
deviates from the IUPAC recommendation to give atom names as 
superscripts to the atom type, this is done to make the figure easier to read.   
The atoms of the side chain are given Greek letter names, starting from the Cα in 
Figure 5, to identify their position in the side chain. IUPAC suggested names are 
given as superscripts to the atom type [53]. Numbers are added to differentiate 
between atoms that are equally distant from the Cα, like the two amine nitrogen of 
arginine, Nη1 and Nη2. The protons on Nη1 and Nη2 are given a number to reflect 
which nitrogen they are attached to, and a number to distinguish them from each 
other. The protons on Nη1 are thus Hη11 and Hη12, whereas the protons on Nη2 are Hη21 
and Hη22. The atoms involved in the peptide bond are given names according to the 
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functional group they belong to. Thus, the two protons (H) in the figure are the amid 
proton, HN and the Hα, the carbons are the carbonyl carbon, designated C, and the 
carbons of the side chain, Cα and on, the nitrogen are the amid one, designated N, and 
the nitrogen of the side chain, Nε and on, the oxygen is the carbonyl one, designated 
O’. The CYANA software utilized in the analysis of NMR data in this thesis uses a 
slightly different nomenclature: there are no Greek letters and no superscript. 
Consequently, the Hα is called HA, HN is H. Atoms with equal distances to CA (Cα) 
are given numbers like in the IUPAC nomenclature; the protons on NH1 (Nη1) and 
NH2 (Nη2) are thus called HH11 (Hη11), HH12 (Hη12), HH21 (Hη21) and HH22 (Hη22). 
In cases where there are two or more equivalent protons, like the three HB (Hβ) of 
alanine, and one can not determine which one gives rise to what resonance, or they all 
have the same chemical shift, H is substituted with Q. In the text, IUPAC 
nomenclature will be used, but when referring to CYANA output, CYANA 
nomenclature will be used with IUPAC nomenclature in parenthesis.   
2.2.3 Chemical shift referencing 
The dependency of the Larmor frequency on the static magnetic field, leads to a 
dependency of the chemical shift on the static magnetic field [49]. The use of a 
common internal standard allows chemical shift referencing independent of field 
strength, and for this reason Wishart and colleagues compared different compounds 
in current use, and found sodium 2, 2-dimethyl-2-silapentan-5-sulphonate (DSS) to 
be a good referencing compound [54]. Chemical shifts are reported as an offset, δ or 
ppm, from the referencing compound frequency: 
610)()(   referenceppm  
Formula 10 
where σ is the resonant frequency of the spin in question, Ω, divided by the 
transmitter frequency ω [48]. 
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2.2.4 J-coupling 
J-couplings are through bond interactions between spins, mediated by the electrons 
that make up the bond. In general, all spins involved in some sort of bond, covalent or 
hydrogen, are J-coupled. The magnitude of the coupling is described by the J-
coupling constant, nJa-b, where n denotes the number of bonds between spin a and b 
[48].  
The coupling modifies the energy levels of the coupled spins; consequently 
modifying the resonant frequencies of the spins, see Formula 7. Two spins, a and b, 
give rise to two resonant frequencies if uncoupled, the same spins give rise to four 
resonant frequencies if coupled. This is called a splitting of spins by J-coupling. The 
split resonant frequencies are centered, in pairs, around the uncoupled a and b 
frequencies, deviating from these with ½ nJa-b in positive and negative directions, see 
Figure 6 [48]. 
The magnitude of a 3J-coupling is dependent upon the dihedral angle formed by the 
three bonds. This leads to the possibility of gaining information about protein/peptide 
dihedral angles, in particular the dihedral angles of the backbone, from coupling 
constants [48]. See section 3.8.4 for an explanation of backbone dihedral angles.  
Below is a schematic presentation of the energy states of a spin. 
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Figure 6 The static magnetic field leads to non-degeneracy of the α and β energy 
states of a spin. The chemical environment of the spin will shield or deshield the 
spin from the effect of the static magnetic field causing a decrease (not shown in 
figure) or increase in ΔE Larmour by ΔE CS (Chemical Shift). A J-coupling will 
further modify the chemically changed Larmour frequency of a spin by adding and 
subtracting ¼ Δ EJ from the high and low energy states of the spin. The two 
allowed transitions between the new energy states, the dashed lines, differ from the 
chemically shifted ΔE Larmour by ½ ΔE J in positive and negative direction. The 
energy difference is proportional to the resonant frequency of the spin. 
2.2.5 Relaxation 
Once perturbed from their equilibrium state Boltzmann distribution, the spins will 
return towards this equilibrium state through a process known as relaxation [48]. In 
general, relaxation is described as two steps reversing the effect of perturbation by a 
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pulse; the coherence gained is lost through what is known as spin-spin relaxation, and 
the distribution across the energy states is restored through spin-lattice relaxation 
[48]. Spin-spin relaxation results in loss of detectable signals and is generally the 
faster of the two, whereas consecutive scans cannot be preformed until the spin-
lattice relaxation is complete, restoring +z-direction magnetization [48]. 
Relaxation affects the line width and sensitivity of spectra, and dictates the minimum 
time between consecutive scans and must thus be taken into consideration when 
designing an experiment, but the effects of relaxation on the finished spectrum also 
offers information about the relaxing molecule [48], see section 2.2.6 about the 
Nuclear Overhauser Effect below.     
2.2.6 Nuclear Overhauser Effect, NOE  
The NOE is a change in a spin’s signal strength caused by cross-relaxation of dipolar 
coupled spins [48].  
A dipolar coupling is a through space effect spins have on each other due to their 
dipolar magnetic moments [48].   
Cross relaxation is the dependency of the temporal evolution of one spin’s 
longitudinal magnetization on the state of another spin’s longitudinal magnetization 
[48]. 
In theory, the intensity of the NOEs are inversely proportional with the sixth power of 
the distance between two nuclei. There are, however, effects that cause the NOEs to 
deviate from this distance proportionality. The varying chemical environments of 
nuclei in a molecule will in turn cause varying relaxation pathways; some nuclei will 
rely heavily on dipol-dipol relaxation, increasing NOE intensities, whereas others 
might relax through alternative mechanisms, decreasing NOE intensities. Differences 
in internal molecular motions may also lead to differences in NOE growth rates. 
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Dipol-dipol interactions tend to be dominated by the pair of nuclei that are closest to 
each other, so a NOE from one nuclei to a second may be reduced by a third that is 
closer. Internal distances may also vary over time as molecules assume different 
conformations [49]. 
It is therefore with caution NOEs are used to give specific intra molecular distances. 
NOE data are usually used to give upper distance limits for the separation of nuclei. 
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2.2.7 Data acquisition and prossesing 
An electromagnetic wave with a direction of propagation perpendicular to the above 
defined z-axis will create a magnetic field perpendicular to that axis. This will cause 
the spins to start a precession about the direction of this new magnetic field [49]. In 
NMR terms, this is a pulse. The power, duration and phase of the pulse dictates what 
direction in the coordinate system the net magnetization will have as a result of the 
pulse [49]. The frequency of the pulse dictates which type of spin it affects, as the 
frequency has to match the precessional frequency of that nuclei [49].   
The detector of an NMR instrument is made such that it can only detect 
magnetization in the x-y plane of the above defined coordinate-system [49]. At 
equilibrium there is magnetization in the x-y plane, but magnetization vectors 
pointing in all directions cancel each other out, leaving no detectable net 
magnetization [49]. Pulses, or sequences of pulses with or without time gaps between 
them, are used to perturb magnetization from equilibrium to a desired state and to 
transfer magnetization to the x-y plane. Magnetization transferred to the x-y plane has 
phase coherence as a consequence of the pulses, this leads to detectable net 
magnetization in the x-y plane [49]. 
The Free Induction Decay (FID) is a time dependent display of an oscillating voltage 
in the receiver coil of the detector, caused by precessing magnetization in the x-y 
plane [49]. This time dependent signal has to be transformed into a frequency domain 
signal. This is done via Fourier transformation of the digitized signal. Figure 7 gives 
a schematic presentation of the effect of the Fourier transform. 
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Figure 7 The time dependent Free Induction Decay is Fourier transformed 
to display the intensities of the signal as a function of frequency. 
The Fourier transform can be preformed by a number of algorithms. It is based on a 
general relationship between a time domain function, s(t), and a frequency domain 
function S(ν) [48]:  



 dtetsS vti  2)()(  
Formula 11 
2.2.8 Multi Dimensional NMR 
The unprocessed NMR signal, the FID, is a time domain display of oscillating 
currents caused by nuclei precessing in the detector coil. To obtain net magnetization 
to detect in the x-y plane, nuclei are perturbed from equilibrium by an 
electromagnetic pulse. The fourier transformed FID gives rise to a one dimensional 
NMR spectrum [49]. To obtain greater dimensionality, one has to perturb the nuclei 
an additional time and introduce a variable time (t1) block between the pulse blocks. 
Figure 8 gives a schematic presentation of a two-dimensional NMR experiment. An 
explanation of the different blocks is given beneath the figure. 
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Figure 8 Schematic display of a 2D NMR experiment. Between the 
preparation pulse, P, and the mixing pulse, M, there is an evolution block, 
E. The duration of the E-block, t1, is altered between consecutive scans. 
Thus a second time dependency is introduced into the FID, giving rise to a 
second dimension. 
The preparation pulse-sequence (P) manipulates the system, ensuring a desired state 
of magnetization which is to evolve (E) during the t1 block. The specific sequence 
may be a single pulse or a complex array of pulses, depending on the type of 
experiment[49].  
The mixing pulse-sequence (M) transfers coherence between spins. The specifics of 
the sequence determine through which couplings coherence is transferred, and thus 
which correlations are seen in the finished spectrum [49]. 
During the detection block (D), the magnetization is measured as a function of time 
(t2). As t1 is augmented throughout consecutive scans, information about the effect of 
these increments is gathered, i.e. magnetization is measured as a function of time. 
Double Fourier-transformation of these two time-domains, t1 and t2, gives two 
frequency-domains, a 2D spectrum [49].  
The spins are said to be F1 frequency labeled during the t1 period. This means that the 
frequencies the spins precess with during t1 are the ones displayed in the F1 
dimension of the final spectrum [48].   
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Additional variable time blocks can be added followed by additional mixing in order 
to increase the dimensionality further [48].  
2.2.9 TOtal Correlation SpectroscopY, TOCSY  
TOCSY is a 2D spectrum with proton frequencies in both dimensions used to map 
continuous chains of J-couplings, e.g. the J-coupling chains in amino acid side 
chains. 
After a 90o pulse, a spin-lock pulse sequence stops all chemical shift evolution. 
During the spin-lock, correlation is transferred through J-couplings, but, as all nuclei 
have the same chemical shifts, they are indistinguishable and the J-coupling is 
relayed until there is a break in the continuous chain of coupled nuclei or the spin 
lock is turned of. Approximately 15 ms is needed to relay J-coupling between protons 
on neighboring carbons [49]. 
The pattern of peaks from protons J-coupled to HN is called the fingerprint of the 
amino acid, TOCSY is used to display the entire fingerprint in one spectrum. 
However, TOCSY cross peak intensities vary, as the mixing time (spin-lock 
sequence) varies. Therefore, a series of spectra with increasing mixing time is often 
used. This is done both to make sure all peaks are found, and to monitor cross-peak 
intensities as a function of mixing time. Protons distal (proximal) to HN may have 
higher (lower) intensities at longer mixing times. This means that cross-peak 
intensities relative to mixing time may give information about which protons the 
different peaks originate from [48].    
2.2.10 Hetronuclear Single Quantum Correlation, HSQC 
HSQC is a 2D spectrum with proton frequencies in the F2 dimension and the 
frequencies of heteronuclei in the F1 dimension [48].  
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An Insensitive Nuclei Enhancement through Polarization Transfer (INEPT) sequence 
transfers proton magnetization to the nuclei to which the proton is bound (x-nuclei). 
A reverse INEPT sequence transfers magnetization back from the x-nuclei to the 
protons for detection after evolution [48]. 
HSQC is used to map 1J-couplings between protons and the x-nuclei they are attached 
to, x being for example 13C or 15N. HSQC is also used to expand 2D proton-proton 
experiments to 3 or 4D, and thus to separate overlapping proton peaks based on their 
more highly resolved heteronuclear coupled partners [48]. 
2.2.11 Nuclear Overhauser Enhancement SpectroscopY, NOESY 
NOESY is a 2D proton-proton spectroscopic method. A sequence of two pulses 
moving the net magnetization 90o in the coordinate system, separated by an evolution 
delay, t1, generates F1 frequency labeled spins and restores magnetization in the +z 
direction. The spins then evolve under the influence of the dipolar couplings for a 
duration known as the mixing time of the experiment, before a final pulse creates 
detectable magnetization [48]. 
The NOESY spectrum consists of diagonal and off-diagonal peaks. The diagonal 
peaks reflect the chemical shift of the spins, whereas the off-diagonal peaks correlate 
dipolar coupled spins [48]. The off-diagonal peaks thus contain information about 
inter-molecular distances, see section 2.2.6. 
2.2.12 HNHA 
HNHA is a 3D spectrum correlating HN, Hα and 15N of one residue. The ratio of the 
intensities of the diagonal HN-HN-15N peak and the Hα- HN-15N crosspeak provides a 
measure for the 3JHNHα coupling constant: 
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Scross and Sdiagonal are the integrated volumes of the Hα- HN-15N crosspeak and the HN-
HN-15N diagonal peak, respectively. ζ is the evolution delay, a pulse-sequence 
parameter [55].  
The dihedral angle between HN and Hα is found by fitting the coupling constant to a 
Karplus curve: 
 2coscos CBAJ HH N   
Formula 13 
where θ is the dihedral angle [55].  
2.2.13 3D, TOCSY-/NOESY- HSQC 
In order to increase resolution, a 15N/13C HSQC pulse sequence is incorporated into 
these two 2D proton-proton techniques. As the low natural abundance of 15N and 13C 
and the low γ of 13C rises signal strength issues, these techniques are usually 
preformed on isotope enriched samples [48]. The resulting spectrum is like a stack of 
proton-proton spectra, one per 15N/13C chemical shift. I.e. protons coupled to 
heteronuclei with different chemical shift will be in different layers of the stack [48]. 
Below is an illustration of the resolution gains with this method: 
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Figure 9 Although the heteronuclei chemical shifts are continuous, the 
resolution gains of a 3D NOESY-/TOCSY- HSQC spectrum is often 
illustrated as having a stack of 2D spectra where each layer represents a 
specific heteronuclei chemical shift.   
 34 
 
3. Materials and methods 
3.1 Vector DNA 
 The expression vector used in the work for this thesis was pGEV-2, into which was 
inserted a gene fusion encoding a fusion protein consisting of, N-terminaly, the 
immunoglobulin binding domain of Streptococcal protein G (GB1 domain), and, C-
terminaly, PlnJ. The vector with gene inserts as described was kindly provided by Per 
Rogne (PhD student, IMBV, University of Oslo, Norway). The target peptide-GB1 
fusion expression system has been specifically designed for fast, high yield 
expression of small peptides for NMR characterization [56]. The pGEV-2 vector, 
with out gene inserts, was provided by Dr Gronenborn (National Institute of Diabetes 
and Digestive and Kidney Diseases, Bethesda, USA). The vector contains a strong 
inducible promotor with a downstream gene encoding the GB1 domain and a linker 
region. The linker region contains a protease factor Xa cleveage site. However, this 
cleavage site was not used to cleave off mature PlnJ. Instead, the vector was modified 
such that the codon for methionine, ATG, was placed immediately upstream of the 
first codon of PlnJ [44], thus facilitating the use of CNBr to cleave the fusion peptide.  
3.2 Preparation of competent Escherichia coli cells, CaCl2 
method 
0.5 ml over night E. coli culture was added to 25 ml fresh LB media (see Appendix) 
and incubated at 37oC until the optical density at 600 nm (O.D600) (see Appendix) 
reached 0.3 (E. coli BL-21) or 0.5 (E. coli TB-1). The culture was cooled on ice, 10 
minutes, and the cells were pelleted (centrifugation at 5000 rpm and 4oC for 10 min). 
Cells were then resuspended in 5 ml ice cold 0.1 M CaCl2 solution and kept on ice 
for 5 minutes before they were pelleted again (centrifugation at 5000 rpm and 4oC for 
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% 10 min). The cells were finally resuspended in 1 ml ice cold 0.1 M CaCl2 with 15 
(v/v) glycerol and kept on ice for 10 minutes before they were stored at -80oC in 50 
µl aliquots. 
3.3 Transformation of competent E. coli TB-1- and BL-21- 
cells  
TB-1 cells were transformed for amplification and storage of the pGEV2 vector with 
PlnJ-GB-1 gene fusion inserted (see section 3.1). For peptide production, BL-21 cells 
were transformed, with this vector isolated from TB-1 cells (see 3.4),. 
50 µl of cells were thawed on ice. Vector DNA, with PlnJ-GB-1 gene fusion insert 
(see section 3.1) was added, 1/20 volumeDNA/volumecells. The cells were then 
incubated for 30 minutes on ice, prior to heat shock, 90 seconds at 42oC. The cells 
were incubated on ice for 2 minutes before they were transferred to 1 ml SOB media 
(see Appendix), preheated to 37oC. The cells were incubated, with shaking, for one 
hour at 37oC. 
50 µl of the BL-21 cells were plated on M9 minimal media with agar (see Appendix) 
in petri dishes. The petri dishes were wrapped in plastic and incubated at 30oC over 
night. The following day the dishes were inspected for cell growth. Dishes with well 
defined and isolated cell-colonies were stored at 4oC, wrapped in plastic, for use in 
for production of peptide.  
50 µl of the TB-1 cells were plated LB media with agar (see Appendix) in Petri 
dishes. After over night incubation at 30oC, 8 well defined isolated cell colonies were 
transferred to 3 ml LB media each and incubated over night at 37oC with vigorous 
shaking. After over night incubation, two different 3 ml LB media cultures, 
containing different clones of the TB-1 cells, were selected randomly amongst the 
cultures showing cell growth. 1 ml of each of the two were transferred to eppendorf 
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tubes and 200 µl glycerol was added before the tubes were stored at -800C to serve as 
a stock for production of DNA to use in sequencing and transformation of BL-21 for 
expression. 
3.4 Purification of plasmid DNA from E. coli TB-1 
DNA was isolated using Quiaprep Spin Miniprep (Quiagen) and Nucleo Spin 
Plasmid (Macherey Nagel) plasmid DNA purification kits. 
E. coli TB-1 from the -80oC stock (see 3.3) was grown overnight in 3 ml LB media. 
A sterile pipette tip was used to scrape a few cells out of the tube of frozen cells and 
transfer these to the LB media. 1 ml cell culture was centrifuged at 13,000 rpm for 30 
seconds in a tabletop centrifuge (see Appendix), the supernatant was discarded. Cells 
were resuspended in 250 µl Buffer A1 and vortexed. 250 µl Buffer A2 was added and 
the solution inverted 6-8 times to carefully mix. The solution was incubated at room 
temperature for one minute before adding 300 µl Buffer A3 and carefully mixing by 
inverting 6-8 times. 
These steps assure lysis of the cells and precipitation of genomic DNA along with 
remains of the cells. Plasmid DNA is in solution. Careful mixing after adding Buffers 
A1 and A2 is to avoid shearing of genomic DNA, which would result in genomic 
DNA in solution and consequent contamination of purified plasmid DNA. 
The solution was centrifuged at 13,000 rpm for 10 min and the supernatant was 
loaded onto a spin column supplied with the kit. The spin column was placed inside a 
tube designed to collect the flow through and centrifuged at 13,000 rpm. The flow 
through was discarded and 600 µl Buffer A4 was loaded onto the column. The 
column was centrifuged twice; first at 13,000 rpm for 1 minute, then at 13,000 rpm 
for 2 minutes, the flow through was discarded both times. 
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These steps assure that the plasmid DNA binds to the column, that unbound 
contaminations are washed of the column and that the column is dry. 
50 µl Buffer AE is loaded onto the column and left to incubate for 1 minute at room 
temperature before placing the column in a clean eppendorf tube and eluting purified 
plasmid DNA by centrifuging at 13,000 rpm for one minute, collecting the flow 
through in the eppendorf tube. 
In this final step, pure plasmid DNA is eluted from the column. 
The above protocol is for the Macherey-Nagel kit, the procedure is identical for the 
Quiagen kit. The exact composition of the various buffers is not revealed, but the 
general composition of the buffers is as follows: 
 A1 - Resuspension buffer 
 A2 – SDS/alkaline lysis buffer 
 A3 – Neutralizing buffer, creates appropriate conditions for binding DNA to 
the silica membrane of the NucleoSpin Plasmid column. 
 A4 – Ethanol wash buffer 
 AE – elution buffer, 5 mM Tris/HCl, pH (: 
3.5 Production and purification of PlnJ 
Following transformation, BL-21 cells were grown on M9 agar in Petri dishes. 
Colonies from the Petri dishes were grown in LB media over night and 5-10 ml were 
used to inoculate 1 liter of LB media to produce cells for expression of peptide. These 
large volume cultures were grown to OD 0.6-0.7 prior to harvesting the cells by 
centrifugation at 6000 rpm (see Appendix) and 4oC for 10 minutes. The cells were 
washed in 1x M9 salt solution (see Appendix) and resuspended in 250 ml 15N labeled 
M9 media. Before inducing transcription of the GB-1 PlnJ gene fusion by adding 
isopropyl-beta-D-thiogalactopyranoside (IPTG) to an end concentration of 1 mM, the 
cell culture was allowed a one hour growth recovery and clearance of unlabeled 
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metabolites. Four hours after induction, cells were harvested by centrifugation at 
6,000 rpm and 4oC for 10 minutes.   
Lysis of the cells was preformed on the Express (see Appendix): The cells were 
submerged in liquid nitrogen, crushed into a “frozen cell powder” and poured into a 
metal cylinder. To prevent thawing of the cells, the metal cylinder was kept in a -
18oC freezer overnight before use. The cylinder was blocked in the middle by a disc 
with a small hole in it, about one millimeter, the cylinder was thus divided into two 
compartments, between which passage is only possible through the small hole in the 
blocking disc. A piston was entered into the same cylinder-compartment as the cells, 
and the open end of the other compartment was blocked. The cylinder was placed in a 
hydraulic press, and 5-6 tons of pressure was applied to the piston, forcing the cells 
through the small hole in the blocking disc. The cylinder was turned around and the 
cells pressed back into compartment they were first placed in. The cells were pressed 
back and forth three times. The cells were lysed mechanically. Ice-crystals in- and 
out- side the cells sheared the cells as they were pressed through the small hole. 
Lysis was followed by resuspension in 20 ml MQ water per one liter LB media 
culture. 
To solubilize proteins in inclusion bodies, guanodine hydrochloride was added to an 
end concentration of approximately 3 M, and the lysate was incubated in a 500C 
water bath for 1.5 h. To clear insoluble substances from the supernatant, the lysate 
was centrifuged at 12,500 rpm and 4oC for 20 minutes. To prepare for purification of 
the target peptide, the supernatant was diluted approximately 5 times in H2O with 0.1 
% tetraflouroacetic acid (TFA), centrifuged at 12,500 rpm (see Appendix) and 4oC 
for 20 minutes and filtered through a 2 µm syringe filter.  
Purification of the fusion protein was performed on the Äkta system (see Appendix). 
The fusion protein was applied to a ResourceRPC 3 ml column (see Appendix), 
equilibrated with H2O and 0.1 % TFA and eluted from the column with a 0 to 100 % 
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linear 2-propanol containing 0.1 % TFA gradient over 10 column volumes in H2O 
with 0.1 % TFA. The flow rate was 1 ml/minute.  
Peak fractions containing the fusion protein collected from the ResourceRPC 3ml 
purification step were treated with cyanogen bromide to cleave the target peptide 
from its fusion partner prior to purification on a Vydac c18 column. Approximately 
47 ml of collected fractions were distributed into 40 eppendorf tubes and dried over 
night on a vacuum centrifuge (see Appendix). The content of the tubes was 
resuspended in 1 ml 0.1 M hydrochloric acid each and a small CNBr crystal, about 2 
mg, was added.  
A rule of thumb states that for CNBr cutting of small peptides, adding equal amounts, 
by weight, of peptide and CNBr assures the appropriate excess of CNBr. 
Alternatively, the molar amount of CNBr needed can be determined by multiplying 
the molar amount of methionines to be cut by 10. The amount of CNBr used in this 
study exceeded the amounts dictated by both of these methods.  
The tubes were wrapped in aluminum foil and left for 12-14 hours before they were 
opened and the water, CNBr, HCl and volatile side products of the cutting reaction 
were allowed to evaporate. To speed up the evaporation, a stream of N2 gas was led 
over each sample. The content of each tube was resuspended in 850 µl H2O and left 
over night to vent off remaining excess CNBr, HCl and volatile side products before 
it was diluted five times in H2O with 0.1 % TFA and applied to the Vydac column. 
The target peptide was eluted from the Vydac reverse phase column with the same 
buffers and flow rate as on the RescourceRPC columne, but with a gradient to 100% 
over 20 column volumes.  
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3.6 Mass spectrometry 
PlnJ was expressed as part of a fusion peptide together with the GB1 domain as 
described above. It was therefore not possible to screen fractions collected during 
purification for bacteriocin activity until after cleaving of the fusion peptide. A 
MALDI-TOF type spectrometer (see Appendix) was used to determine the molecular 
weights of peptides/proteins contained in the different fractions collected during 
purification. Before cleaving, sinapinic acid was used as matrix, after cleaving α-
cyano-4hydroxycinnamic acid was used. The matrix was dissolved in water, 10 
mg/ml, and 0.5 µl droplets were applied to a sample plate followed by immediate 
application of 0.5 µl aliquots of column fractions onto the droplets. The 
sample/matrix mix was allowed to dry before one spectrum of 50 shots was collected 
per fraction  
3.7 Bacteriocin assay 
50 µl of MRS media (see Appendix) were added to all wells on a micro-titer plate. 
Another 45 µl of MRS media, 2.5 µl of different column fractions and an excess of 
synthetic plnK (relative to the estimated amount of bacteriocin in the column 
fractions) was added to all wells in the first column of wells. The approximately 100 
µl in the first column of wells were mixed and 50 µl were removed from each well 
and added to the next column of wells and mixed. Then, 50 µl were removed from 
that column of wells and added to the next column of wells and mixed. This process 
was repeated until 50 µl were added to the last column of wells and after mixing, 50 
µl were removed from these wells and discarded. The result is two-fold dilution of 
the sample compared to the previous column of wells. Each row contained a different 
column fraction combined with synthetic plnK. An indicator strain was added to all 
wells. This indicator strain consisted of an over-night culture of Lactobacillus 
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plantarum 965 diluted 200 times in MRS media. To serve as a reference for growth 
inhibition, one well was not added any bacteriocin, only indicator strain and MRS 
media. The plate was then incubated at 30oC over night before cell densities were 
determined, relative to the reference well, spectrophotometrically (see Appendix).    
3.8 Circular Dichroism spectroscopy 
CD measurements (see Appendix) were preformed in a quarts cuvette with a light 
path of 0.1 cm. The wavelength range was 190-260 nm. Data pitch was 1 nm and 
response time 2 seconds, while scanning was continuous at 50 nm/min. Protein 
concentration ranged from 5.0 x 10-5 to 4.6 x 10-5 molar. 
Measurements were performed on peptide in increasing concentrations of DPC to 
determine an appropriate concentration for NMR studies. To verify that the peptide 
was unstructured in water, as expected, a DPC free sample was measured. To mimic 
the conditions in a NMR sample, an aqueous buffer containing 0.1 % TFA was used.  
The samples were composed of a volume of aqueous buffer containing 0.1 % TFA to 
which volumes of peptide and DPC standard solutions were added to reach desired 
concentrations. The names and compositions of the samples are specified in section 4 
Results and discussion, Table 4.2.1, along with results of CD measurements.  
The peptide standard solution was made by diluting a sample of the peptide produced 
for use in NMR studies. The concentration of the peptide sample was determined by 
UV/visible spectroscopy. Beer-Lamberts Law was used to calculate the 
concentrations from the spectroscopic measurements. The DPC solution was made by 
weighing out an amount of dry DPC and dissolving it in an appropriate amount of 
water. 
The data was analyzed with the helical content at the different DPC concentrations in 
mind. Both the single wavelength method and the full spectrum method were used for 
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analysis. The single wavelength method uses molar residual elipticity at 222 nm 
([θ]222) to calculate the helical content (%α): 
 
 n5.2140000%100% 222
  
Formula 14 
 whereas the full spectrum method relies on the CDPro software package [57], which 
compares the CD spectra with a reference set containing spectra of proteins with 
known 3D structures. 
 43 
 
3.9 NMR 
3.9.1 Acquisition and data prosessing 
0.47 mg 15N PlnJ, produced and purified as specified above, was dissolved in 270 µl 
MQ H2O containing 0.2 mM DSS, 0.1 % TFA and 10 % D2O. The end concentration 
of peptide was 0.59 mM. This was the sample used to acquire all 3D NMR spectra 
(see Appendix). 
1.75 mg synthetic PlnJ was dissolved in 600 µl of the same buffer as the 15N peptide 
sample, giving an end concentration of 1 mM. This sample was used for all the 2D 
NMR spectra. 
To induce structuring, DPC was added to the samples. 10 mg was added to the 15N 
PlnJ sample, 42 mg to the synthetic PlnJ sample. The difference in the amount of 
DPC is due to the difference in amount of the produced and the synthetic sample. 
The lower volume of the 15N sample required the use of a Shigemi NMR tube (see 
Appendix), specially designed for low volume samples. The synthetic peptide was 
studied in a standard 5 mm NMR tube. 
The pulse-sequences used to acquire the 3D HSQC-TOCSY and 3D HSQC-NOESY 
are described in papers by Palmer et al, Kay et al and Sceucher et al [58-60]. Mixing 
times used were  150 ms for HSQC-NOESY and 80 ms for HSQC-TOCSY. Pulse-
sequences used for 2D NOESY and  2D TOCSY are described by Bax et al and 
Hwang et al [61, 62]. The HSQC pulse-sequence is described by Davis et al [63]. The 
pulse-sequence for HNHA is described by Vuister and Bax [55], the evolution delay, 
ζ, was 13.05 ms.  
The number of complex data points for the different dimensions of the various 
spectra are as follows: 2D HSQC; 2048 direct dimension, 32 indirect dimension, 
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TOCSY and NOESY; 4096 direct dimension, 512 indirect dimension, TOCSY-
HSQC; 2048 direct dimension, 21 nitrogen indirect dimension, 160 proton indirect 
dimension, NOESY-HSQC; 2048 direct dimension, 24 nitrogen indirect dimension, 
256 proton indirect dimension.  
By adding points with the value zero, the number of complex data points was 
rounded up to the nearest number N, satisfying N = 2n, where n is any positive 
integer, and then doubled. After rounding, the total number of complex data points 
was 2 x 2n. 
3.9.2 Assignement 
The resonances of the nitrogen in the side chains of arginine and tryptophan have 
been folded in so that they appear in the spectra even though they actually fall outside 
the sweep width of the spectra. 
To assign a protein NMR spectrum is to determine which atom of which amino acid 
gives rise to which signal.  
A 2D nitrogen-proton HSQC spectrum was used to determine the chemical shifts of 
1J coupled nitrogen and proton. Shift values were used to locate N-H-H diagonal 
peaks in a 15N TOCSY-HSQC spectrum.  
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Figure 10 below shows areas of the 15N PlnJ HSQC spectrum expected to contain 
different categories of 1J coupled nitrogen and 
proton
 
Figure 10 HSQC spectrum showing 1J coupled 1H and 15N of plantaricin J. 
Squares 1 and 2 show areas containing side chain amines of tryptophan 
and arginine, respectively. Square 3 contains remaining side chain amines. 
The rest of the peaks are back bone amid groups. The bulk of amid groups 
fall in the area below 15N 115 ppm, whereas serines are expected above 
115 ppm and glycines above 110 ppm. 
Starting from the N-H-H diagonal peak, all peaks belonging to the same spin-system 
are located. A spin-system is a series of J-coupled spins. Effects of J-couplings across 
the peptide bond are not detectable, therefore all peaks in a spin-system arises from 
one amino acid. It is, however, not necessarily so that a spin-system contains all 
peaks arising from one amino acid; J-couplings between the backbone amid proton of 
amino acids with aromatic R groups and protons in the aromatic ring are not 
detectable. In addition, some amino acids give rise to two or more spin-systems, and 
the spins giving rise to the peaks in each of these may or may not be J-coupled. 
Arginine contains four nitrogen (see Figure 5) and gives rise to four spin-systems in 
15N TOCSY-HSQC; these are divided into two pairs, N/Nε and Nη1/Nη2. Within each 
pair, the proton chemical shifts are the same; i.e. the signals arise from the same 
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protons, but no proton gives rise to a peak in both of the two pairs of spin-systems 
since J-couplings are not detectable across the Nε-Cζ bond. It should be noted that 
some peaks may not be visible in the spectrum, and some proton shifts may be 
overlapping. Consequently, spin-systems may display less peaks than theoretically 
possible. On the other hand, overlapping amid proton and nitrogen shifts for two 
spin-systems will cause these to be displayed on top of each other, appearing to be 
one spin-system with many peaks. 
The amid proton spin-system, all protons with detectable J-couplings to the amid 
proton, is used as a starting point when deducing which amino acid gives rise to 
which spin-system. When comparing the theoretical amid spin-systems of all 20 
amino acids, 11 spin-system types emerge; Figure 11 shows these 11 spin-system 
types.  
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Figure 11 Theoretical fingerprint of the 20 standard amino acids, divided 
into 11 spin-system types. Filled circles, filled triangles, open squares, open 
triangles represents  Hα, Hβ, Hγ, Hδ, respectively. 
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In the lower left centre of the HSQC (see Figure 10), there is a peak at approximately 
15N-125 ppm, H-9 ppm. Assignment started with this peak. Figure 12 shows the spin-
system associated with this amid group. 
 
Figure 12 The spin-system of the amid group with chemical shift 9.034-
9.034.124.6 (H-H-15N). Comparison with Figure11 shows that this is most 
likely an alanine. 
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This spin-system was found to most likely be originating from an alanine when 
compared to Figure 11.  
Ones the amid spin-systems have been assigned to a group, sequential assignment 
starts. A 15N NOESY-HSQC spectrum was overlaid on the 15N TOCSY-HSQC 
spectrum, that way non-TOCSY type peaks would be easy to see. First, the NOE’s 
between amid protons were mapped. In helical structures, a NOE between HN of 
sequential neighbours is expected, see Table 4. 
Table 4 Expected NOE effects in an α-helical protein 
Nuclei sequence NOE effect 
H-H, i-i+1   (HN-HN,i,i+1) Strong 
HA-H, i-i+1   (Hα-HN,i,i+1)   Weak 
HA-H, i-i+2   (Hα-HN,i,i+2) Medium 
HA-H, i-i+3   (Hα-HN,i,i+3) Medium 
HA-H, i-i+4   (Hα-HN,i,i+1) Medium 
HB-H, i-i+1   (Hβ-HN,i,i+1) Medium 
H-H, i-i+2   (HN-HN,i,i+2) Medium 
HA-HB, i-i+3   (Hα,Hβ,i,i+1) Medium/strong 
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Figure 13 shows an example of how the NOE’s of the above assigned alanine is used 
to find its sequential neighbor: 
 
Figure 13 Three spectrum strips showing NOE’s between an alanine ( later 
A2) and a tryptophan (later W3). Left and right are the TOCSY-HSQC 
alanine strip (same as Figure 14) and the TOCSY-HSQC tryptophan strip, 
respectively, in the middle is the NOESY-HSQC strip of the alanine spin-
system. Lines are drawn from the TOCSY-HSQC alanine strip to the 
NOESY-HSQC alanine strip to show intra residue NOE’s, and from the 
TOCSY-HSQC tryptophan to the NOESY-HSQC alanine to show alanine-
tryptophan inter residue NOE’s.  
 51 
 
When two or three-spin-systems have been linked by inter amid-proton NOE’s, the 
sequence is checked to see if a string of amino acids that gives rise to such linked 
spin-systems can be found. If such a string only can be found at one place in the 
sequence, the spin-systems are assigned to these amino acids. The A and the W 
connected in the above example form a unique sequence string found only in position 
two and three of the sequence, the sequential assignment A2 and W3 are therefore 
given.  
The easiest way to continue would be to find the sequential neighbors of the already 
assigned amino acids until the entire peptide was mapped, but even for a small 
peptide like PlnJ several strings of spin-systems have to be matched against the 
sequence. Gaps between spin-system sequence matches must be filled by exploring 
other NOE’s, as all the spin-systems form a self consistent web of connectivity’s. 
The assignment of side chain protons might be a straight forward case of matching 
the chemical shifts of TOCSY spin-systems against average reported chemical shifts 
for that amino acid. For other amino acids, like tryptophan, it might involve 
identifying another spin-system. Figure 14 shows the assignment of ring-protons of 
W3 as an example: 
In the upper left corner of the HSQC spectrum, Figure 10, there is a peak at 15N 
108.5 ppm H 10.6 ppm. This peak is positioned in the part of the spectrum where W 
NE/HE1 (Nε/Hε1) HSQC peaks are expected, and consequently checked for NOE 
connections with W NH (NH) spin-systems in a NOESYHSQC spectrum. A 
connection with W3 was found, and it was concluded that this was W3 NE/HE1 
(Nε/Hε1) (see Figure 14).  
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Figure 14 From left to right: W3 NH (NH)  spin-system, NOESYHSQC and 
TOCSYHSQC strips; W3 NE (Nε)  spin-system NOESYHSQC and 
TOCSYHSQC strips. Lines are drawn between the strips to show NOE’s 
connecting the two spin-systems. The HD (Hδ) of the ring was identified by 
being the only proton with a TOCSY connection to HE1 (Hε1). Lines are 
drawn out of the strips to mark the remaining ring protons; these were 
assigned by matching NOE-peaks with peaks belonging to TOCSY-W-ring 
spin-systems (see Figure 17). W3 HE3 (Hε3) cannot be seen due to overlap 
with W3 HD (Hδ). 
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The HE3 (Hε3), HZ2 (Hζ2), HZ3 (Hζ3) and HH2 (Hη2) protons of the W ring are all 3J-
coupled, and consequently form spin-systems in TOCSY. They are, however, not 3J 
coupled to any proton sitting on a nitrogen and do therefore not show up in the 15N 
edited TOCSYHSQC. In Figure 15, four interconnected 2D TOCSY spin-systems are 
shown. These where assigned to the W3 HE3 (Hε3), HZ2 (Hζ2), HZ3 (Hζ3) and HH2 
(Hη2) ring protons as they also appear as NOE’s in the W3 NE (Nε) NOESYHSQC 
strip of Figure 14. 
 
Figure 15 Four interconnected spin-systems in a 2D TOCSY spectrum. 
Corresponding NOE peaks were found in the NE (Nε) strip of W3, see 
Figure 16, identifying these as W3 HZ3 (Hζ3) (6.8 PPM), HH2 (Hη2) (7 PPM) 
HZ2 (Hζ2) (7.4 PPM) and HE3 (Hε3) (7.5 PPM).    
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After identifying these as the W3 ring protons, each peak had to be assigned to one of 
the ring protons. This was achieved by both matching the proton chemical shifts of 
the peaks against average reported chemical shifts [50], and the relative intensities of 
the NOE’s between the members of the spin-system, see Figure 16. 
 
Figure 16 The intraresidual distances of the W3 ring is reflected in its 2D 
NOESY spectrum: the NOE between HZ3 (Hζ3) and HE3 (Hε3) is more 
intense than the one between HZ3 (Hζ3) and HZ2 (Hζ2) due to the smaller 
distance between HZ3 (Hζ3) and HE3 (Hε3), square 1. The distance between 
HH2 (Hη2) and HE3 (Hε3) is greater than between HH2 (Hη2) and HZ2 (Hζ2), 
consequently the HH2 (Hη2) -HZ2 (Hζ2) NOE is the most intense, square 2. 
3.9.3 Stuctural data 
Table 4 lists expected NOE’s in an α-helical protein. Most of these involve a proton 
attached to a nitrogen, these will show up in the NOESYHSQC spectrum used in 
assignment, and were assigned during this process. The Hα-Hβ i-i+3 will not, 
therefore the 2D NOESY spectrum used in the assignment of W3 ring protons above, 
was used to assign these NOE’s. Since CYANA will automatically assign NOE’s 
based on input about the chemical shifts of the spins in the amino acids of the protein, 
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it is crucial to get the assignment of these correct. The NOE cross peaks have to be 
integrated properly in order for the calibration of them to be correct. Calibration is the 
process of relating NOE cross peak intensities to the distance between the cross 
relaxing spins. The intensities of the HNHCα cross peaks were determined through 
integration, and the 3JHNHα was calculated using Formula 12. 
3.9.4 Cyana 
Combined assignment and dYnamics Algorithm for Nmr Applications, Cyana, is a 
program for automated assignment of NOESY crosspeaks, and structure calculation 
using a torsion angle dynamics algorithm. 
The most important input for CYANA is the Nuclear Overhauser Effects, NOEs, of 
the molecule. These NOEs have to be assigned, that is, the protons whose dipole 
moments interact have to be identified. CYANA will do this, provided there is a list 
of the chemical shifts of the nuclei in the protein. There are, however, always NOEs 
that cannot be unambiguously assigned. To counter the effects of this, multiple 
possible assignments are considered for each ambiguous NOE, weighting them 
according to the inverse of the distance between the protons [64]. Furthermore, all 
possible assignments are scored according to their network anchoring, which is how 
well an assignment complies the network of other assignments [64].  
Once NOEs are assigned, structure calculations can start. 
The structure calculation is based on molecular dynamics, but uses the torsion angles 
of the protein as the only degrees of freedom. Simulated rises in temperature provide 
the (virtual) kinetic energy to prevent the structure from getting stuck in a local 
minimum as the lowest energy structure is sought [64]. 
Structures provided by the torsion angle dynamics step are evaluated by a target 
function. Distance constraints based on the assigned NOEs are taken into 
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consideration. The target function gives a lower score the more torsion angle- and 
distance- constraints are met [64]. 
3.9.5 Chemical Shift Indexing 
The chemical shift of nuclei in a molecule varies according to the chemical 
environment they are in. The chemical environment of a nucleus in a given molecule 
will vary with the structure of the molecule; the orientation of nearby nuclei may 
vary, and distant nuclei may gain proximity through structural features such as loops. 
The chemical shift of Hα of amino acids varies consistently in accordance with the 
secondary structure of the protein. When compared to Hα of random coil proteins, 
those of α-helical proteins show an averaged 0.3 ppm lower chemical shift, and those 
in β-sheet structures show an averaged 0.3 ppm higher shift [65]. Chemical Shift 
Indexing is assigning amino acids to one of three different groups based on how the 
chemical shifts of their Hα compare to those of the same amino acid in random coil. A 
chemical shift less than random coil – 0.1 ppm will assign an amino acid to the α-
helical group. A chemical shift more than random coil + 0.1 ppm will assign an 
amino acid to the β-sheet group. In between these two is the random coil group. A 
string of three or more from one group indicates a possible secondary structure 
element, or lack of such [66].  
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3.9.6 TALOS 
TALOS is software that uses empirical data to predict phi, φ, and psi, ψ, torsion 
angles in proteins. These torsion angles are used as angle constraints in further 
structural calculations. Figure 17 illustrates the torsion angles predicted by TALOS. 
 
Figure 17 a) The φ and ψ torsion angles represents a rotation about the Cα-N and 
the Cα-C bonds, respectively. b) View down the Cα-N bond:  A change in the φ 
angle constitutes a change in the distance between the C of two consecutive 
residues. c) View down the Cα-C bond: A change in the ψ angle constitutes a 
change in the distance between the N of two consecutive residues.   
Data from three consecutive amino acids is used to make a prediction about the 
central of the three. TALOS compares data to that of known structures and predicts 
based on homology. The data points are Hα, Cα, Cβ, C and N chemical shifts, or the 
ones available. The amino acid type is also taken into consideration; a scoring system 
biases the prediction towards being based on data from similar sequences. The 
TALOS data base consists of chemical shifts from 186 proteins [52]. 
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4. Results and discussion 
4.1 Production, purification, molecular weight and activity 
The yield of PlnJ per liter LB cell culture was approximately 0.1 mg; consequently 
the procedure had to be scaled up and repeated to produce the amount needed for 
NMR studies. The final yield of PlnJ was 0.47 mg with molecular weight 2970. 
Compared to the molecular weight of the non 15N-labled peptide, 2929, this indicates 
that 99 % of the nitrogen in the produced peptide are 15N. The sample was tested for 
activity (see section 3.6) and found to be active. Figures 18 and 19 present 
chromatograms from the purification process. 
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Figure 18 Chromatogram from purification on the RescourceRPC 3ml 
column. The x-axis is milliliters. The large peak at approximately 32 ml was 
collected for CNBr cutting and further purification. This chromatogram is 
representative for one tenth of the peptide production achieved from a one 
liter inoculated LB media when prepared as described in Section 3.5.   
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Figure 19 Chromatogram from purification on the Vydac218TP5100 
column. X-axis is milliliters. The fastest eluting of the two large peaks, at 
approximately 152.5 ml, was collected. The slower eluting peak contained a 
peptide with molecular weight 3010. This chromatogram is representative 
of the peptide production achieved from four liters of inoculated LB media 
when prepared as described in section 3.5.      
The final 0.47 mg sample was tested for purity on the SMART system (see 
Appendix) and found to be pure. However, due to computer breakdown, the 
chromatogram is not available. 
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4.2 Circular dichroism 
To determine the appropriate concentration of DPC in the sample for investigation by 
NMR, CD spectra of peptide in NMR buffer containing increasing concentrations of 
DPC were acquired. Results are presented in Table 5 below. Sample preparation is 
described in section 2.1 Circular Dichroism. Figure 20 is a plot of Molar Residue 
Elipticity throughout the wavelength range of the CD spectra.   
Table 5 Sample composition and helical content of PlnJ, determined by use 
of the single wavelength and full spectrum methods. αd + αr indicates that 
the helical content calculated with the full spectrum method is the sum of 
310- and α- helical content. The PlnJ0DPC sample was made by combining 
130 µl H2O + 0.1 % TFA and 7 µl 2 mg/ml PlnJ. Subsequent samples were 
made by adding DPC to this sample. 
Final 
concentrations, M 
Sample 
name 
 
Amount 
added 
0.1M 
DPC [DPC] [PlnJ] 
[DPC] / 
[PlnJ] 
Helical content 
Single 
Wavelength 
method 222 nm 
Helical content 
Full Spectrum 
method 
αd + αr 
PlnJ0DPC 0 0 5.0 
x10-5 
- 3.7 % 2 % 
PlnJ2DPC 2 µl 1.4 x10-3 5.0 
x10-5 
28 8.7 % 5.2 % 
PlnJ4DPC 4 µl 2.8 x10-3 4.9 
x10-5 
57.1  24.2 % 48.8 % 
PlnJ6DPC 6 µl 4.2x10-3 4.8 
x10-5 
87.5 25.6 % 46.5 % 
PlnJ8DPC 8 µl 5.5 x10-3 4.8 
x10-5 
114.6 26.5 % 45.5 % 
PlnJ12DPC 12 µl 8 x10-3 4.6 
x10-5 
173.9 25.6 % 43.3 % 
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Figure 20 Plot of MRE, molar residue elipticity, as a function of wavelength 
for samples containing different amounts of DPC. For sample composition 
see Table 5. 
Comparison of Figure 3 and Figure 20 shows that samples 4-12 DPC give CD 
spectra indicating α-helical structure. The 0 DPC sample spectrum has a random coil 
shape, whereas the 2 DPC sample spectrum shows changes from random coil which, 
given the results of the 4-12 DPC samples, might be considered as α-helical 
structuring. However, on its own the 2 DPC spectrum is ambiguous. Results 
presented in Table 4 lead to the same conclusions as Figure 20. The findings concur 
with those of Hauge et al. [18], although the samples of Hauge et al. were composed 
of peptide and DPC dissolved in 20 mM sodium phosphate buffer instead of H2O 
with 0.1 % TFA.      
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4.3 Chemical Shift Indexing 
The amino acids of PlnJ were assigned to three different groups according to the shift 
of Hα. To accommodate graphical presentation, the groups were given the values -1 
for α-helical, 0 for random coil, and 1 for β-sheet. 
0 0 0
-1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
0
-1 -1 -1 -1
0 0 0 0 0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
 
Figure 21 The figure shows that 16, or 64%, of the 25 amino acids of PlnJ 
are assigned to the α-helical group (-1). In addition to giving a quantitative 
measure, the results also reveal that the helical content is divided in two 
groups located at amino acids 4 through 15 and 17 through 20. 
Figure 21 shows that 16 out of the 25 amino acids of PlnJ were assigned to the α-
helical group. This was as expected and further confirms initial CD results indicating 
that PlnJ adopts an α-helical structure when exposed to a membrane mimicking 
substance (DPC). 
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4.4 TALOS 
TALOS dihedral angle predictions are presented as an angle with a standard 
deviation. These predictions are modified before use as input for the CYANA 
program; Table 6 below shows an allowed range for the phi and psi angles of 17 of 
PlnJ’s 25 amino acids, the minimum of the range represents the TALOS output angle 
minus 2.5 standard deviations, the maximum represents the TALOS output plus 2.5 
standard deviations. 
Table 6 The table presents modified dihedral angle predictions for 17 of the 
25 amino acids of PlnJ made by the TALOS program. Predictions can not 
be made for the N- and C- terminal amino acids, unambiguous predictions 
could not be made for the remaining amino acids missing from the list. 
Residue 
Type/number 
Angle Minimum 
degree 
Maximum 
degree 
K 4 PHI -98.5 -30.1 
K 4  PSI -76.2 -4.9 
N 5 PHI -88.3 -38.3 
N 5 PSI -66.1 -16.1 
F 6 PHI -122.3 -17.1 
F 6 PSI -79.6 -6 
W 7 PHI -86.2 -36.2 
W 7 PSI -70.6 -20.6 
S 8 PHI -88.1 -38.1 
S 8 PSI -67.2 -17.2 
S 9 PHI -88.6 -38.6 
S 9 PSI -70.1 -20.1 
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L 10 PHI -87.3 -37.3 
L 10 PSI -68.2 -18.2 
R 11 PHI -85.8 -35.8 
R 11 PSI -68.9 -7.8 
K 12 PHI -132.8 -15.3 
K 12 PSI -77.9 19.8 
F 14 PHI -91.5 -41.5 
F 14 PSI -74.9 2.8 
Y 15 PHI -89.7 -39.7 
Y 15 PSI -64.9 -14.9 
D 16 PHI -120.5 -51.5 
D 16 PSI -68 43.2 
E 18 PHI -92.3 -34.5 
E 18 PSI -87.3 11.3 
A 19 PHI -102.3 -35.2 
A 19 PSI -88.1 20.6 
R 21  PHI -104.9 -33.1 
R 21 PSI -64.2 -7.2 
A 22 PHI -92.5 -42.5 
A 22 PSI -67.4 2.7 
I 23 PHI -123.4 -36.3 
I 23 PSI -66.3 18.9 
 
A perfect α-helix has dihedral angles φ -57and ψ -47, the distorted α-helix, the 310 
helix, has angles φ -49 ψ -26 [67]. All of these angles fall within the ranges allowed 
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by Table 6. The TALOS data thus allows the α-helical structure indicated by CD and 
CSI.    
4.5 3JHNHα couplings of PlnJ 
3JHNHα coupling constants for 18 of PlnJ’s 25 amino acids are presented in Table 7 
below. Coupling constants for glycine residues 1, 13, 17 and 20 were not calculated 
since glycine has two Hα and consequently two coupling constants. Coupling 
constants are not reported for F6, W7 and L10 since no HNHα cross peaks were found 
in the spectrum. This might suggest that the coupling constants are so small that the 
peaks are of lower intensities than the noise of the spectrum, which in turn would 
make them smaller than the smallest one reported here; R11 1.65.  
Table 7 3JHNHα coupling constants, in hertz, of 18 of PlnJ’s 25 amino acids.  
Residue 3JHNHα 
coupling 
constants 
G1 - 
A2 2.97 
W3 3.32 
K4 1.95 
N5 3.83 
F6 - 
W7 - 
S8 1.85 
S9 3.33 
L10 - 
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R11 1.65 
K12 3.24 
G13 - 
F14 4.49 
Y15 7.38 
D16 3.47 
G17 - 
E18 2.31 
A19 3.29 
G20 - 
R21 4.93 
A22 3.71 
I23 6.05 
R24 5.9 
R25 5.3 
 
A 3JHNHα of 3.9 Hz is expected for a perfect α-helix, 4.2 Hz for a 310-helix, but 
stretches of three or more amino acids with 3JHNHα less than 6 is considered an 
indication of a helical structure [68]. Apart from Y15 and I 23, all the amino acids 
have 3JHNHα lower than 6 Hz. There is, however, just one stretch of three or more 
amino acids with 3JHNHα lower than 6 Hz; A2 – N5. On the other hand, if one were to 
assume that amino acids F6, W7 and L10 all had 3JHNHα lower than R11 at 1.65 Hz, 
amino acids A2 through K12 would form a continuous string of 3JHNHα lower than 6 
Hz.  
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4.6 Structure calculation of plantaricin J 
CYANA returns 20 different structures based on the structural data input. Structures 
1 through 20 have a mean target function value (see section 3.9.4) of 0.95, the 
minimum value is 0.86 (Structure 1), the maximum 1.06 (Structure 20). Non-NOE 
structural data is presented in sections 4.4 and 4.5. The Upper distance Limit (UPL) 
list of NOE derived constraints is given in the appendix (section 5.5).  
Figure 22 gives three different least square fits of the final 20 structures, Table 8 
gives the root mean square deviation (RMSD) of these fits. 
Figure 23 is a ribbon animation of structure 1, showing two helical structure elements 
separated and flanked by less structured sections composed of turns and bends. The 
N-terminal helical element runs from residue 3 through 13, the C-terminal helical 
element runs from residue 18 through 21. In Figure 24 the non-polar side chains have 
been colored red, and the polar blue, to display the amphiphilic nature of Structure 1.      
Figure 25 is a summary of the NOE derived distance constraints.  
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Figure 22 Least square fit of the final 20 structures. a) Least square fit of all 
25 residues. b) Least square fit of residues 3-12. c) Least square fit of 
residues 19-23. Figures made with MOLMOL [69]. The N-terminus is to the 
left in all three views. 
Table 8 Root Mean Square Deviation of fits over different residue ranges. 
Backbone denotes the continuous chain of carbons and nitrogen connected 
by the peptide bond, and the carbonyl oxygen. 
Fit over residues RMSD, backbone 
1-25 0.47 +/- 0.20 Å 
2-12 0.32 +/- 0.20 Å 
19-23 0.05 +/- 0.03  Å 
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Figure 23 Ribbon animation of Structure 1, N-terminus to the left. The 
unstructured part between the two helices is residues 14 through 17, the 
XXXG part of the GXXXG motif. Figure made with MOLMOL [69]. 
 
Figure 24 View of the amphiphilic nature of PlnJ. Non-polar side chains of 
residues A2, W3, F6,W7, L10, F14, A19, A22 and I23 are colored red. 
Polar side chains of residues K4, N5, S8, S9, R11, K12, Y15, D16, E18, 
R21, R24 and R25 are colored blue. The view at the top is down the helix, 
from the N-terminal. The bottom view is from the side, the N-terminus is to 
the left. Figures made with MOLMOL [69]. 
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Figure 25 Overview of the NOE derived distance constraints used in the 
structure calculations of PlnJ. a) gives an overview of which residues are 
linked by constraints, and also what nuclei in these residues that are linked 
by constraints. A horizontal line between two sequence positions indicates 
a constraint. For the sequential constraints, the thickness of the lines is 
inversely proportional with the square of the upper distance. b) gives an 
overview of number of constraints per range. c) also gives the number of 
constraints per range, but as part of a bar giving the number of constraints 
per residue. The white part of the bar gives the intra-residual constraints, 
grey sequential constraints and dark grey constraints between residues 2-5 
positions apart in the sequence. 
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4.7 Discussion 
Comparing Figure 25a) with Table 4 reveals that most of the expected NOE 
interactions are present. There are, however, a few points worth mentioning. In α-
helixes, the dα-βi,i+3 (Hα-Hβ,i,i+3) NOEs are expected to be strong, and hence readily 
observable. Based on Figure 23, dα-βi,i+3 (Hα-Hβ,i,i+3) NOEs are expected in the 3-13 
and 18-21 parts of the molecule, eight in total. Only one is reported, between residues 
A19 and A22. The peaks resulting from these NOEs are expected in the same area of 
the spectrum as the intra residue- and sequential- Hα to Hβ peaks, which is crowded. 
Of these eight expected peaks, six are possible, meaning they might be present but 
overlapping resonances make them difficult to isolate and integrate. The S9Hα-K12Hβ 
peak was found, but the constraint was deleted by CYANA as it did not affect the 
structure. The N5Hα-S8Hβ peak was confirmed missing from the spectrum. The 
sequential dN-N (HN-HN,i,i+1) and dβ-N (HN-Hβ,i,i+1) NOEs are lacking between six 
and ten pairs of residues (respectively). This is in large part due to overlapping 
resonances, especially the resonances of residues W3, K4, N5, F6 and W7. The 
sequential Hα-HN NOEs are also missing between some residues. Resonance overlap 
is a reason for this as well, but, because they are generally weaker than the other 
sequential NOEs, the distance constraints they cause are so generous they have no 
impact on the structure; consequently CYANA has ignored some of them. Although 
there are some NOEs missing, all the NOEs present are expected in an α-helical 
structure. The NOE data alone can thus not be considered proof of an α-helix, but as 
an indication of one. 
Figure 25b) shows that about a third of the NOEs are intra-residue, another third are 
sequential and the remaining third are medium-range. There are no long range 
(between residues more than 5 places apart in the sequence) NOEs. This is all in 
concordance with the suggested α-helical structure. 
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Figure 25c) is a display of numbers of constraints per residue. The residues with the 
fewest constraints are all situated in either the N- or C-terminal, or in sequential 
positions 6-8 or 13-19. These are the unstructured parts of the molecule and the part 
where connectivity’s are difficult to establish due to overlap. 
Preliminary investigation, using CD, revealed that PlnJ had an α-helical structure. 
Chemical Shift Indexing confirmed this, suggesting that there might be a break in the 
structure around residue 16 and at each end of the molecule. Figure 23 shows a 
structure, calculated by CYANA, consisting of two helical regions separated by a 
GXXXG motif spanning residues G13 to G17 with less structuring at the ends, and 
thus concur with preliminary findings.   
The primary sequence of PlnJ reveals that it can form an amphiphilic helix. Figure 24 
shows that this occurs upon interaction with a membrane mimicking entity such as 
DPC. With the hydrophobic side facing the membrane, the hydrophilic side would be 
exposed to the solvent, assuring a thermodynamically favorable positioning of all 
amino acids. Figures 22-24 show that PlnJ appears to adopt a structure without 
pronounced bends that would position parts of the molecule in another plane or 
orientation than the rest of the molecule. This could indicate that the molecule lies 
flat along the surface of the micelle. It appears that the N-terminal part, up to W7, 
could be submerged deeper into the micelle before the polar residues come in conflict 
with the micelle, as K4 and N5 have their side chains directed away from the 
hydrophobic side. R11, Y15 and E18 on the other hand have their polar side chains 
pointed towards the hydrophobic side, limiting how far this part of the molecule 
could be submerged. This allows PlnJ to be positioned in the micelle such that the 
extrapolated long axis of the molecule would draw a secant through a thought 
spherical micelle rather than a tangent. Figure 26-27 shows both possibilities. 
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Figure 26 PlnJ embedded in micelle, long axis tangent to the micelle 
surface. The pink field is the micelle surface. Figure made with MOLMOL 
[69]. 
   
 
Figure 27 PlnJ embedded in micelle, long axis secant to the micelle 
surface. The pink field is the micelle surface. Figure made with MOLMOL 
[69]. 
In Figure 26, W3, F6 and W7 are less deeply embedded in the micelle. The 
orientation shown in Figure 27 embeds the aromatic side chains of the N-terminal 
region deep in the micelle.  
It is important to realise that DPC is used as a membrane mimicking structuring 
agent, not as a model of a target cell. The importance of hydrophobic interactions in 
peptide folding [67] combined with the fact that PlnJ is unstructured in water 
suggests that the hydrophobic amino acid residues play a part in the structuring of 
PlnJ. Their interaction with the DPC micelles resembles that with a cell-membrane 
and therefore gives a realistic view of the structuring of PlnJ [46]. The two 
components of plantaricin J/K, PlnJ and PlnK, do, however, not show increased 
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structuring when combined with DPC together. Thus, DPC micelles can not serve as 
a system for revealing the interaction of the two peptides, only their individual 
structures.  
Site directed mutagenic studies combined with structural and functional studies have 
proven useful in revealing the role of individual amino acid residues in the structuring 
and bactericidal effect of bacteriocins [19, 43, 70]. There has been preformed a 
mutagenic study on plantaricin J/K showing that the low bulk of the glycine side 
chains in position 13 and 17 of both peptides is important for the function of the 
bacteriocin: glycine to alanine mutation are far less detrimental to activity than 
glycine to lysine mutations (Rogne, unpublished). The other positions in the GXXXG 
motif are flexible with regards to amino acid side chain bulk and charge, suggesting 
they do not serve any specific function. It is thus likely that the PlnJ and PlnK 
peptides of plantaricin J/K interact through the GXXXG motifs, more specifically the 
glycines, spanning residues 13-17 in both peptides. CD studies of PlnK have revealed 
that it too adopts an α-helical structure when exposed to DPC micelles [18], which 
makes it possible that the tertiary structure of plantaricin J/K is similar to that which 
has been suggested for other two-peptide bacteriocins: two parallel helices [19, 44]. 
However, if PlnJ and PlnK were to lay in an anti parallel and staggered way, glycine 
13 of one peptide interacting with glycine 17 of the other, then the positive charges of 
the C-terminus of PlnJ and the N-terminus of PlnK would make plantaricin J/K polar, 
see Table 9 bottom cell. The mode of action suggested for lactococcin G, relies on a 
positive charge being pulled through the cell membrane of the target cell, towards the 
electrically negative inside of the cell [44]. This mode of action would be more 
plausible in the anti parallel alignment, as a total of 7 positive charges come together 
at the PlnJ C-term/PlnK N-term part of the molecule, see Table 9 bottom cell.     
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Table 9 Distribution of charged amino acid residues in parallel (top) and 
anti parallel (bottom) interactions between PlnJ and PlnK. Positively 
charged amino acid residues coloured red, negatively charged blue. The 
sequences are aligned such that the GXXXG motifs (bold case), which are 
thought to interact, are opposite each other. It should be noted that this is a 
sequence alignment, displaying what general part of the molecule 
(plantaricin J/K) charged amino acid residues are located in, and not a 
display of relative positioning of amino acids in the structured molecule.      
PlnJ N-term    GAWKNFWSSLRKGFYDGEAGRAIRR 
PlnK   N-term RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK 
PlnJ          N-term GAWKNFWSSLRKGFYDGEAGRAIRR 
PlnK               KNYDRSGGLVAREVAGFAYGIAYGIGNKRSRR N-term 
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5. Appendix 
5.1 Hardware 
Optical density measurements: Shimadzu UV 160 A spectrophotometer. 
Centrifugation 6,000 rpm: Beckman Coulter J2-MC, JA 10 rotor. 
Centrifugation 12,500 rpm: Beckman Coulter Avanti J-20 XP, JA 25.50 rotor. 
Tabletop centrifuge 13,000 rpm: Kendro Heraeus Biofuge Pico, 24x1.5 ml place 
rotor. 
Cell lysis: Express, AB Biox. 
Chromatography: ÄKTA purifier; pump P-900, UV-metre UV-900, fraction collector 
Frac-950, injection valve INV-907, mixer M-925, Unicorn software. Amersham 
biosciences 
Chromatographic columns: RescourceRPC 3 ml, 15µm polystyrene/divinylbenzene 
ads, Amersham biosciences. Vydac 218TP510, n-octadecyl reverse phase based on 
300 Å silica, Grace Vydac. 
Mass spectrometry: Voyager-DE RP MALDI-TOF spectrometer, PerSeptive 
Biosystems. 
Vaccume centrifuge: Saveant Speed Vac concentrator, Savant Instruments Inc. 
Bacteriocin assay: microplate reader, SUNRISE 
Circular dichroism: Jasco J-810 spectropolarimeter  
NMR spectroscopy: 600 MHz Bruker Avance II spectrometer. Shigemi tubes, Sigma 
Aldrich 
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5.2 Chemicals 
Acetonitril  Merck 
α-cyano-4-hydroxycinnamic acid 
   Sigma Aldrich 
Agar   Merck 
Ampicilin  Calbiochem 
Biotin   Merck 
CaCl2   Merck 
Chloramphenicol Sigma Aldrich 
CNBr   Sigma Aldrich 
CoCl2 * 6 H2O Merck 
Guanodine hydrochloride 
   Sigma Aldrich 
H3BO3  Merck 
IPTG   VWR 
KCl   Merck 
MgCl2   AppliChem 
MgSO4  Merck 
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MnCl2 * 4 H2O Merck 
MRS   Oxoid 
NaCl   AnalR 
NaH2PO4  Merck 
Na2HPO4  Merck 
15NH4Cl  Sigma Aldrich, Isotec 
2-propanol  Merck 
3, 5-Dimethoxy-4-hydroxycinnamic acid (Sinapinic acid)  
Sigma Aldrich 
Sodium 2, 2-dimethyl-2-silapentan-5-sulphonate (DSS) 
   Larodan AB 
Thiamin  Sigma Aldrich 
Trifluoracetic acid Sigma Aldrich 
Tryptone  Merck  
Yeast extract  Merck 
ZnSO4 * 7 H2O Merck 
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5.3 Media and solutions 
M9 minimal media 
Per litre: 
100 ml   M9 salts (10x) 
10 ml    trace element solution (100x) 
20 ml    20% (w/v) glucose 
0.5 g    NH4Cl 
1 ml    1M  MgSO4 
300 µl   1M CaCl2 
2 ml   0.5 mg/ml biotin 
1 ml   1mg/ml thiamin 
   Antibiotics 
Ingredients, exept glucose, biotin, thiamin and antibiotics were dissolved in 977 ml 
MQ H2O and autoclaved for 20 minutes at 121oC. Then the remaining ingredients 
were added. Glucose had been autoclaved on its own, biotin, thiamin and antibiotic 
had been passed through a 0.5 µm syringe-filter. Antibiotics used were ampicilin, end 
concentration 100 µg/ml, and chloramphenicol, end concentration 50 µg/ml. To make 
plates, 1.5 % agar was added before the media was poured onto Petri-dishes. 
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M9 salts (10x) 
Per litre: 
60 g   Na2HPO4 
30 g   KH2PO4 
5 g   NaCl 
Dissolve in 1000 ml MQ H2O, autoclave for 20 minutes at 121oC. 
Trace element solution (100x) 
Per litre: 
5 g   EDTA 
830 mg  FeCl3 * 6 H2O 
177 mg  ZnSO4 * 7 H2O 
19 mg   CuSo4 * 2 H2O 
10 mg   CoCl2 * 6 H2O 
10 mg   H3BO3 
1.3 mg  MnCl2 * 4 H2O 
Dissolve EDTA in 750 ml MQ H2O, adjust pH to 7.5 with NaOH. Dissolve rest of 
ingredients, add MQ H2O until total volume is 1000 ml.  
SOB media 
Per litre: 
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20 g   tryptone 
5 g   yeast extract 
2 ml   5M NaCl 
2.5 ml   1M KCl 
10 ml   1M MgCl2 
10 ml    1M MgSO4 
Dissolv in < 1000ml MQ H2O, adjust to 1000 ml. Autoclave 20 minutes at 121oC. 
LB media 
Per litre: 
10 g   NaCl 
10 g   tryptone 
5 g   yeast exstract 
Dissolve in < 1000ml MQ H2O, adjust to 1000 ml. Autoclave 20 minutes at 121oC. 
Antibiotics used were ampicilin 100 µg/ml (E. coli TB-1 and BL-21) and 
chloramphenicol 50 µg/ml (E. coli BL-21). To make plates, 1.5 % agar was added 
before the media was poured onto Petri-dishes. 
MRS 
Ready made, mix only (see Appendix, Chemicals). Autoclave at 121oC for 20 
minutes. 
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5.4 Chemical shifts of PlnJ 
CYANA nomenclature. 
Group    Atom    Nuc              Shift     
    G1          QA          1H         3.889         
 
    A2      HA    1H   4.261     
    A2     HN       1H      9.035    
    A2       N   15N         124.565   
    A2     QB    1H      1.409    
 
    W3      HA      1H      4.558     
    W3     HD1     1H      7.327    
    W3     HE1      1H             10.671        
    W3     HE3      1H      7.462    
    W3      HN     1H      8.805    
    W3       N    15N          119.574    
    W3      QB      1H      3.380     
 
    K4      HA      1H      4.109   
    K4     HG2     1H      1.759            
    K4     HG3     1H      1.550     
    K4      HN      1H      8.334     
    K4       N    15N          120.002     
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    K4      QB      1H      1.934     
    K4      QD      1H      1.461     
 
    N5      HA      1H      4.563   
    N5    HD21    1H      7.853     
    N5    HD22    1H      6.986     
    N5      HN       1H      8.326   
    N5       N    15N          117.887     
    N5     ND2    15N         112.756     
    N5      QB      1H      2.919     
 
    F6      HA      1H      4.290     
    F6     HB2     1H      3.232    
    F6     HB3     1H      3.154     
    F6     HD1     1H      6.984     
    F6     HD2     1H      7.075     
    F6     HE1      1H      7.469    
    F6     HE2      1H      7.855     
    F6      HN      1H     8.325     
    F6      HZ      1H      6.874    
    F6       N    15N          122.552     
 
    W7      HA      1H      4.027   
    W7     HB2     1H      3.214     
 90 
 
    W7     HB3     1H      3.367     
    W7     HE3      1H      7.442     
    W7      HN      1H      8.356     
    W7     HZ2      1H      7.092     
    W7     HZ3      1H      6.876     
    W7       N    15N          112.936     
 
    S8      HA      1H     4.284     
    S8      HN      1H      8.340     
    S8       N    15N        119.781   
    S8      QB      1H      4.108     
 
    S9      HA      1H      4.156     
    S9     HB2     1H      3.969     
    S9     HB3     1H      3.747     
    S9      HN      1H      7.906     
    S9       N    15N          117.975     
 
   L10      HA      1H      3.872     
   L10      HG      1H      1.384    
   L10      HN      1H      8.010     
   L10       N    15N          124.017     
   L10      QB    1H      1.391     
   L10     QQD    1H      0.695     
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   R11      HA    1H      3.700     
   R11     HB2     1H      1.846     
   R11     HB3     1H      1.690     
   R11      HE    1H      7.449   
   R11    HH11    1H      7.174     
   R11    HH21   1H      7.104     
   R11    HH22    1H      6.868     
   R11      HN      1H      8.034     
   R11       N    15N          117.968     
   R11      NE    15N          106.522     
   R11      QD     1H      3.073     
   R11      QG      1H      1.417     
 
   K12      HA    1H      4.072     
   K12     HD2    1H      1.520     
   K12     HD3     1H      1.438    
   K12      HN      1H      7.766     
   K12       N    15N          117.936   
   K12      QB    1H      1.839     
   K12      QE    1H      2.940     
   K12      QG      1H      1.673     
 
   G13     HA2     1H      3.965     
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   G13     HA3    1H      3.630     
   G13      HN    1H      8.132    
   G13       N   15N          106.172     
 
   F14      HA    1H      4.241     
   F14     HB2    1H      2.953     
   F14     HB3    1H      3.153     
   F14      HN      1H      8.110     
   F14      HZ    1H      6.773     
   F14       N   15N          117.161     
   F14      QD    1H      6.846     
   F14      QE    1H      7.181   
 
   Y15      HA    1H      4.246     
   Y15     HB2     1H      3.158     
   Y15     HB3      1H      2.965     
   Y15      HN    1H      8.202     
   Y15       N    15N          120.673    
   Y15      QD    1H      6.771     
 
   D16      HA      1H      4.620     
   D16     HB2    1H      3.112     
   D16     HB3    1H      2.906     
   D16      HN    1H      8.341     
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   D16       N  15N          117.348    
 
   G17     HN     1H      7.916     
   G17       N   15N          107.893   
   G17      QA    1H      3.974     
 
   E18      HA    1H      4.064     
   E18      HN    1H      8.280     
   E18       N  15N          120.303    
   E18      QB    1H      2.022     
   E18      QG      1H      2.349     
 
   A19      HA    1H      4.050     
   A19      HN    1H      8.289     
   A19       N    15N          121.292     
   A19      QB    1H      1.319     
 
   G20     HA2    1H      3.889     
   G20     HA3    1H      3.746     
   G20      HN    1H      8.151     
   G20       N   15N         104.693     
 
   R21      HA    1H      4.155     
   R21     HB2    1H      1.818    
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   R21     HB3    1H      1.711     
   R21      HE    1H      7.345          
   R21      HN    1H      7.723     
   R21       N    15N          119.079     
   R21      NE   15N          106.276    
   R21      QD    1H      3.148     
   R21      QG    1H      1.572     
 
   A22      HA    1H      4.178     
   A22      HN    1H      8.006   
   A22       N  15N          121.750     
   A22      QB    1H      1.427  
   I23      HA    1H      4.091     
   I23      HB    1H      1.932     
   I23     HD1    1H      0.851     
   I23     HG2    1H      0.913     
   I23      HN    1H      7.668     
   I23       N   15N          114.719   
   I23     QG1    1H      1.246     
 
   R24      HA    1H      4.324    
   R24     HB2    1H      1.902     
   R24     HB3    1H      1.749     
   R24     HG2    1H      1.693     
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   R24     HG3    1H      1.558     
   R24      HN    1H      7.801     
   R24       N   15N          121.161    
   R24      QD    1H      3.136    
  
   R25      HA    1H      4.269     
   R25     HB2    1H      1.921     
   R25     HB3    1H      1.809    
   R25      HE    1H      7.440     
   R25      HN    1H      8.170     
   R25       N   15N          121.077     
   R25      NE   15N          106.473     
   R25     QD    1H      3.189     
   R25      QG    1H      1.675    
5.5 Upper distance Limits list 
Peak number (#peak) above 10.000 indicates that the constraint is derived from a 2D 
NOESY spectrum. The rest of the peaks are from a 3D NOESY-HSQC spectrum. 
CYANA nomenclature. 
  3 TRP  H       3 TRP  QB      2.92            #peak     3 #SUP  0.95  #QF  0.95 
  2 ALA  H       3 TRP  H       3.61            #peak     4 #SUP  0.99  #QF  0.99 
  2 ALA  QB      3 TRP  H       3.51            #peak     6 #SUP  0.99  #QF  0.99 
 17 GLY  H      18 GLU  H       2.70            #peak     7 #SUP  0.72  #QF  0.72 
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 12 LYS  H      13 GLY  H       3.92            #peak     8 #SUP  1.00 
 12 LYS  QB     13 GLY  H       3.99            #peak    11 #SUP  0.99  #QF  0.99 
 12 LYS  QG     13 GLY  H       3.26            #peak    13 #SUP  0.90  #QF  0.90 
 10 LEU  HA     13 GLY  H       4.55            #peak    15 #SUP  0.87  #QF  0.87 
 20 GLY  H      21 ARG  H       3.43            #peak    18 #SUP  0.99  #QF  0.99 
 19 ALA  H      20 GLY  H       3.59            #peak    19 #SUP  0.97  #QF  0.97 
 18 GLU  HA     20 GLY  H       3.73            #peak    22 #SUP  1.00  #QF  0.83 
 19 ALA  QB     20 GLY  H       3.27            #peak    23 #SUP  0.97  #QF  0.97 
 18 GLU  H      18 GLU  QG      3.48            #peak    24 #SUP  0.91  #QF  0.91 
 18 GLU  H      18 GLU  QB      3.15            #peak    25 #SUP  0.94  #QF  0.94 
 18 GLU  QG     19 ALA  H       4.52            #peak    26 #SUP  1.00 
 18 GLU  QB     19 ALA  H       3.64            #peak    27 #SUP  0.98  #QF  0.98 
 19 ALA  H      19 ALA  QB      2.88            #peak    28 #SUP  1.00 
 14 PHE  HA     17 GLY  H       5.50            #peak    32 #SUP  1.00  #QF  0.96 
 15 TYR  HA     17 GLY  H       5.50            #peak    32 #SUP  1.00  #QF  0.96 
 16 ASP  HB2    17 GLY  H       5.13            #peak    33 #SUP  1.00 
 16 ASP  HB3    17 GLY  H       4.47            #peak    35 #SUP  0.98  #QF  0.98 
 13 GLY  H      14 PHE  HA      5.50            #peak    37 #SUP  0.92  #QF  0.92 
 17 GLY  QA     18 GLU  H       3.05            #peak    39 #SUP  1.00 
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 17 GLY  QA     19 ALA  H       3.81            #peak    41 #SUP  0.82  #QF  0.82 
 19 ALA  H      20 GLY  HA3     5.10            #peak    42 #SUP  0.99  #QF  0.99 
 19 ALA  H      20 GLY  HA2     5.50            #peak    43 #SUP  0.95  #QF  0.95 
 10 LEU  H      10 LEU  QQD     3.72            #peak    44 #SUP  0.99  #QF  0.99 
 20 GLY  H      23 ILE  H       5.03            #peak    52 #SUP  1.00  #QF  0.93 
 22 ALA  H      23 ILE  H       3.36            #peak    53 #SUP  0.93  #QF  0.93 
 22 ALA  H      22 ALA  QB      2.83            #peak    55 #SUP  0.96  #QF  0.96 
 20 GLY  HA3    23 ILE  H       5.50            #peak    58 #SUP  0.98  #QF  0.98 
 21 ARG  HB3    23 ILE  H       5.50            #peak    61 #SUP  0.92  #QF  0.92 
 23 ILE  H      25 ARG  QG      5.50            #peak    62 #SUP  0.92  #QF  0.23 
 22 ALA  QB     23 ILE  H       3.31            #peak    63 #SUP  0.91  #QF  0.91 
 23 ILE  HB     24 ARG  H       3.65            #peak    64 #SUP  1.00  #QF  0.75 
 24 ARG  H      24 ARG  HG3     3.75            #peak    66 #SUP  0.98  #QF  0.98 
 24 ARG  H      24 ARG  HG2     2.85            #peak    67 #SUP  0.54  #QF  0.54 
 24 ARG  H      25 ARG  H       2.76            #peak    68 #SUP  0.81  #QF  0.81 
 22 ALA  H      24 ARG  H       5.48            #peak    69 #SUP  0.93  #QF  0.93 
 23 ILE  HA     24 ARG  H       3.50            #peak    72 #SUP  0.99  #QF  0.99 
 23 ILE  QG1    24 ARG  H       4.40            #peak    74 #SUP  0.98  #QF  0.98 
 23 ILE  QG2    24 ARG  H       3.97            #peak    75 #SUP  1.00 
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 23 ILE  H      23 ILE  QG1     3.54            #peak    77 #SUP  0.99  #QF  0.99 
 23 ILE  H      23 ILE  QG2     3.87            #peak    78 #SUP  1.00 
 18 GLU  H      22 ALA  H       5.50            #peak    79 #SUP  1.00 
 21 ARG  H      22 ALA  H       5.50            #peak    81 #SUP  0.98  #QF  0.98 
  1 GLY  QA      3 TRP  H       4.25            #peak    82 #SUP  0.98  #QF  0.98 
 21 ARG  HA     24 ARG  H       4.69            #peak    91 #SUP  0.97  #QF  0.84 
 22 ALA  HA     24 ARG  H       5.11            #peak    91 #SUP  0.97  #QF  0.84 
 23 ILE  HA     25 ARG  H       4.37            #peak    93 #SUP  0.98  #QF  0.98 
 23 ILE  H      25 ARG  H       4.35            #peak    94 #SUP  0.91  #QF  0.91 
 14 PHE  H      18 GLU  H       5.50            #peak    96 #SUP  0.99  #QF  0.58 
 18 GLU  H      20 GLY  H       5.50            #peak    96 #SUP  0.99  #QF  0.58 
 13 GLY  H      14 PHE  H       3.36            #peak    97 #SUP  0.65  #QF  0.65 
  1 GLY  QA      2 ALA  H       2.80            #peak   101 #SUP  0.99  #QF  0.99 
 10 LEU  QQD    11 ARG  H       4.37            #peak   104 #SUP  1.00 
  7 TRP  HA      9 SER  H       3.75            #peak   105 #SUP  0.85  #QF  0.85 
  9 SER  HA     12 LYS  H       4.41            #peak   106 #SUP  0.93  #QF  0.93 
 12 LYS  H      13 GLY  HA2     4.87            #peak   107 #SUP  0.95  #QF  0.95 
  9 SER  H      10 LEU  HA      5.50            #peak   108 #SUP  0.95  #QF  0.95 
 10 LEU  HA     12 LYS  H       4.49            #peak   109 #SUP  0.94  #QF  0.94 
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 18 GLU  H      21 ARG  H       5.50            #peak   112 #SUP  1.00 
 21 ARG  H      21 ARG  HB3     2.88            #peak   113 #SUP  0.91  #QF  0.91 
 21 ARG  H      21 ARG  HB2     3.31            #peak   114 #SUP  0.97  #QF  0.97 
 21 ARG  H      21 ARG  QG      4.16            #peak   115 #SUP  1.00 
 25 ARG  H      25 ARG  QG      2.59            #peak   119 #SUP  0.83  #QF  0.83 
 14 PHE  H      15 TYR  H       5.50            #peak   120 #SUP  0.28  #QF  0.28 
 22 ALA  H      25 ARG  H       5.50            #peak   121 #SUP  0.95  #QF  0.20 
 25 ARG  H      25 ARG  HE      5.22            #peak   122 #SUP  0.98  #QF  0.98 
 24 ARG  H      24 ARG  QD      3.78            #peak   125 #SUP  0.78  #QF  0.78 
 22 ALA  HA     25 ARG  H       3.92            #peak   126 #SUP  0.73  #QF  0.73 
 25 ARG  H      25 ARG  QD      4.49            #peak   127 #SUP  1.00 
 23 ILE  QG2    25 ARG  H       5.06            #peak   128 #SUP  0.99  #QF  0.99 
  3 TRP  HA      6 PHE  H       3.95            #peak   129 #SUP  1.00  #QF  0.41 
  6 PHE  H       6 PHE  HB2     2.90            #peak   133 #SUP  0.80  #QF  0.80 
  6 PHE  H       6 PHE  HB3     2.90            #peak   134 #SUP  0.88  #QF  0.88 
 11 ARG  H      14 PHE  H       5.50            #peak   136 #SUP  0.78  #QF  0.78 
 23 ILE  H      23 ILE  QD1     4.03            #peak   137 #SUP  0.98  #QF  0.98 
  8 SER  QB      9 SER  H       5.40            #peak   139 #SUP  1.00  #QF  0.99 
  9 SER  H      11 ARG  HB2     5.00            #peak   140 #SUP  0.85  #QF  0.85 
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  9 SER  H      12 LYS  QG      5.50            #peak   141 #SUP  0.90  #QF  0.90 
  9 SER  H      10 LEU  QB      5.50            #peak   143 #SUP  0.99  #QF  0.99 
  9 SER  H      11 ARG  H       5.50            #peak   144 #SUP  0.97  #QF  0.97 
 11 ARG  H      12 LYS  H       5.50            #peak   145 #SUP  1.00 
  7 TRP  HA     11 ARG  H       5.06            #peak   146 #SUP  0.96  #QF  0.96 
  9 SER  HA     11 ARG  H       5.00            #peak   147 #SUP  0.79  #QF  0.79 
 11 ARG  H      11 ARG  HB3     4.16            #peak   151 #SUP  1.00 
 10 LEU  QB     11 ARG  H       3.05            #peak   152 #SUP  0.69  #QF  0.69 
 18 GLU  HA     21 ARG  H       3.47            #peak   153 #SUP  0.85  #QF  0.85 
 20 GLY  HA3    21 ARG  H       3.01            #peak   154 #SUP  0.88  #QF  0.88 
 21 ARG  H      24 ARG  QD      4.27            #peak   155 #SUP  0.66  #QF  0.66 
 21 ARG  H      22 ALA  QB      4.45            #peak   156 #SUP  0.83  #QF  0.83 
 19 ALA  QB     21 ARG  H       4.69            #peak   157 #SUP  0.99  #QF  0.99 
  3 TRP  H       4 LYS  QB      5.39            #peak   158 #SUP  0.99  #QF  0.99 
 14 PHE  HA     18 GLU  H       3.65            #peak   159 #SUP  0.50  #QF  0.50 
 18 GLU  H      19 ALA  QB      4.47            #peak   160 #SUP  0.98  #QF  0.98 
 19 ALA  H      22 ALA  H       5.50            #peak   161 #SUP  1.00 
 17 GLY  H      19 ALA  H       5.24            #peak   162 #SUP  0.97  #QF  0.97 
 19 ALA  H      21 ARG  H       4.59            #peak   163 #SUP  0.99  #QF  0.99 
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 14 PHE  HA     19 ALA  H       3.91            #peak   164 #SUP  0.73  #QF  0.73 
 18 GLU  HA     22 ALA  H       3.80            #peak   165 #SUP  0.82  #QF  0.82 
 20 GLY  HA3    22 ALA  H       4.95            #peak   166 #SUP  0.99  #QF  0.99 
 18 GLU  QB     22 ALA  H       4.19            #peak   168 #SUP  0.87  #QF  0.87 
 21 ARG  HB3    22 ALA  H       3.20            #peak   170 #SUP  0.94  #QF  0.94 
 21 ARG  HB2    22 ALA  H       4.06            #peak   171 #SUP  0.98  #QF  0.98 
 21 ARG  QG     22 ALA  H       3.64            #peak   172 #SUP  0.95  #QF  0.95 
 19 ALA  QB     22 ALA  H       5.50            #peak   173 #SUP  1.00 
 22 ALA  H      23 ILE  QG1     5.50            #peak   174 #SUP  0.88  #QF  0.88 
 22 ALA  H      23 ILE  QG2     5.50            #peak   175 #SUP  0.99  #QF  0.99 
  5 ASN  QB      6 PHE  H       3.00            #peak   176 #SUP  0.68  #QF  0.68 
  9 SER  H      10 LEU  H       5.50            #peak   180 #SUP  1.00 
 10 LEU  H      12 LYS  H       4.89            #peak   181 #SUP  0.99  #QF  0.99 
  7 TRP  HA     10 LEU  H       4.01            #peak   182 #SUP  0.73  #QF  0.73 
  9 SER  HB2    10 LEU  H       4.00            #peak   184 #SUP  0.97  #QF  0.97 
 16 ASP  H      19 ALA  H       5.50            #peak   187 #SUP  0.77  #QF  0.77 
 25 ARG  HB2    25 ARG  HE      5.50            #peak   190 #SUP  1.00 
 11 ARG  HB2    11 ARG  HE      5.50            #peak   191 #SUP  1.00  #QF  0.66 
 25 ARG  HB3    25 ARG  HE      5.50            #peak   191 #SUP  1.00  #QF  0.66 
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 11 ARG  QG     11 ARG  HE      2.98            #peak   193 #SUP  0.87  #QF  0.87 
 11 ARG  H      11 ARG  QD      5.50            #peak   195 #SUP  1.00 
  5 ASN  HA      5 ASN  HD22    4.64            #peak   200 #SUP  0.99  #QF  0.99 
  5 ASN  QB      5 ASN  HD22    3.89            #peak   201 #SUP  1.00 
  3 TRP  H       3 TRP  HE3     4.49            #peak   202 #SUP  0.98  #QF  0.98 
  3 TRP  H       3 TRP  HD1     4.24            #peak   203 #SUP  0.98  #QF  0.98 
 20 GLY  H      21 ARG  HB3     4.01            #peak   204 #SUP  0.97  #QF  0.97 
 20 GLY  H      22 ALA  QB      4.77            #peak   205 #SUP  0.97  #QF  0.97 
 18 GLU  QB     20 GLY  H       5.23            #peak   206 #SUP  0.97  #QF  0.97 
 20 GLY  H      21 ARG  QG      5.50            #peak   207 #SUP  0.96  #QF  0.96 
 20 GLY  H      24 ARG  QD      5.50            #peak   209 #SUP  0.90  #QF  0.90 
 14 PHE  H      16 ASP  H       5.50            #peak   211 #SUP  0.73  #QF  0.73 
 15 TYR  H      16 ASP  H       5.50            #peak   212 #SUP  1.00  #QF  0.79 
 16 ASP  H      17 GLY  H       5.50            #peak   213 #SUP  1.00 
 16 ASP  H      18 GLU  HA      5.50            #peak   215 #SUP  0.77  #QF  0.77 
 15 TYR  QD     16 ASP  H       5.14            #peak   218 #SUP  1.00 
 20 GLY  H      21 ARG  HB2     5.00            #peak   219 #SUP  0.93  #QF  0.93 
 17 GLY  H      18 GLU  QB      4.86            #peak   221 #SUP  0.91  #QF  0.91 
 17 GLY  H      19 ALA  QB      5.12            #peak   222 #SUP  0.98  #QF  0.98 
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 23 ILE  H      24 ARG  H       5.50            #peak   223 #SUP  1.00 
 23 ILE  H      24 ARG  HA      5.50            #peak   225 #SUP  0.98  #QF  0.98 
 20 GLY  HA2    23 ILE  H       3.70            #peak   226 #SUP  0.51  #QF  0.51 
  5 ASN  HA      9 SER  H       5.50            #peak   227 #SUP  0.86  #QF  0.86 
  7 TRP  HB2     9 SER  H       5.50            #peak   228 #SUP  0.97  #QF  0.97 
  5 ASN  QB      9 SER  H       5.50            #peak   229 #SUP  0.92  #QF  0.25 
  9 SER  H      12 LYS  QE      5.50            #peak   229 #SUP  0.92  #QF  0.25 
  9 SER  H      10 LEU  QQD     5.28            #peak   230 #SUP  0.87  #QF  0.87 
 12 LYS  H      12 LYS  QE      4.58            #peak   231 #SUP  0.95  #QF  0.95 
 12 LYS  H      12 LYS  QB      3.17            #peak   232 #SUP  1.00 
 12 LYS  H      12 LYS  QG      2.83            #peak   233 #SUP  0.82  #QF  0.82 
 12 LYS  H      12 LYS  HD2     4.51            #peak   234 #SUP  1.00 
 12 LYS  H      12 LYS  HD3     4.51            #peak   235 #SUP  0.97  #QF  0.97 
 21 ARG  H      21 ARG  HE      4.82            #peak   236 #SUP  0.99  #QF  0.99 
 21 ARG  H      23 ILE  HB      4.96            #peak   237 #SUP  0.49  #QF  0.49 
 18 GLU  QB     21 ARG  H       5.26            #peak   238 #SUP  0.95  #QF  0.95 
 18 GLU  QG     21 ARG  H       5.50            #peak   239 #SUP  0.98  #QF  0.98 
 21 ARG  QD     22 ALA  H       5.35            #peak   240 #SUP  0.95  #QF  0.59 
 22 ALA  H      24 ARG  QD      5.50            #peak   240 #SUP  0.95  #QF  0.59 
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 24 ARG  HG2    25 ARG  H       3.53            #peak   242 #SUP  0.67  #QF  0.67 
 16 ASP  H      16 ASP  HB2     3.22            #peak   246 #SUP  0.72  #QF  0.33 
  2 ALA  QB      6 PHE  H       5.27            #peak   253 #SUP  0.93  #QF  0.93 
  5 ASN  HD21    6 PHE  H       4.27            #peak   254 #SUP  0.80  #QF  0.80 
  6 PHE  H       7 TRP  HE3     4.67            #peak   255 #SUP  0.58  #QF  0.58 
  6 PHE  H       6 PHE  HD2     5.32            #peak   256 #SUP  0.98  #QF  0.97 
  6 PHE  H      11 ARG  HH21    5.50            #peak   256 #SUP  0.98  #QF  0.97 
  6 PHE  H       6 PHE  HD1     5.09            #peak   257 #SUP  0.94  #QF  0.94 
  5 ASN  HA      5 ASN  HD21    4.90            #peak   260 #SUP  0.99  #QF  0.99 
 12 LYS  H      13 GLY  HA3     4.87            #peak   263 #SUP  0.99  #QF  0.99 
 21 ARG  HB3    21 ARG  HE      2.91            #peak   264 #SUP  0.79  #QF  0.79 
 21 ARG  HB2    21 ARG  HE      3.12            #peak   265 #SUP  0.84  #QF  0.84 
 21 ARG  QG     21 ARG  HE      4.07            #peak   266 #SUP  0.99  #QF  0.99 
 21 ARG  QD     21 ARG  HE      2.55            #peak   267 #SUP  0.98  #QF  0.98 
 25 ARG  HA     25 ARG  HE      4.56            #peak   268 #SUP  0.90  #QF  0.90 
  3 TRP  H       5 ASN  H       4.57            #peak   272 #SUP  0.99  #QF  0.99 
  5 ASN  H       5 ASN  QB      2.55            #peak   278 #SUP  0.71  #QF  0.71 
  4 LYS  QB      5 ASN  H       2.91            #peak   279 #SUP  0.84  #QF  0.84 
  2 ALA  QB      5 ASN  H       4.89            #peak   280 #SUP  0.98  #QF  0.98 
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  4 LYS  QD      5 ASN  H       5.17            #peak   281 #SUP  1.00 
  5 ASN  H       5 ASN  HD21    3.75            #peak   286 #SUP  0.97  #QF  0.24 
  5 ASN  H       5 ASN  HD22    4.09            #peak   287 #SUP  0.99  #QF  0.99 
  2 ALA  HA      5 ASN  HD21    3.56            #peak   288 #SUP  0.84  #QF  0.84 
  2 ALA  HA      5 ASN  HD22    5.50            #peak   289 #SUP  0.99  #QF  0.99 
  5 ASN  QB      5 ASN  HD21    2.93            #peak   290 #SUP  0.99  #QF  0.99 
 25 ARG  H      25 ARG  HA      2.79            #peak   293 #SUP  0.94  #QF  0.94 
  4 LYS  QB      6 PHE  H       4.68            #peak   294 #SUP  0.73  #QF  0.73 
 15 TYR  HA     16 ASP  H       3.41            #peak   295 #SUP  0.94  #QF  0.94 
  3 TRP  H       4 LYS  QD      5.19            #peak   297 #SUP  1.00 
  2 ALA  HA      5 ASN  H       3.70            #peak   299 #SUP  0.79  #QF  0.79 
 16 ASP  H      17 GLY  QA      4.55            #peak   301 #SUP  0.26  #QF  0.26 
  2 ALA  H       5 ASN  HD21    5.50            #peak   302 #SUP  0.99  #QF  0.99 
  2 ALA  H       5 ASN  HD22    5.50            #peak   303 #SUP  0.96  #QF  0.96 
  2 ALA  QB      5 ASN  HD21    4.46            #peak   304 #SUP  0.97  #QF  0.97 
  3 TRP  H       6 PHE  H       5.05            #peak   305 #SUP  0.90  #QF  0.90 
  4 LYS  HA      6 PHE  H       4.20            #peak   306 #SUP  0.55  #QF  0.55 
 11 ARG  H      11 ARG  HE      3.68            #peak   309 #SUP  0.88  #QF  0.88 
  9 SER  H      11 ARG  HE      5.39            #peak   310 #SUP  0.89  #QF  0.89 
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 11 ARG  H      11 ARG  HH21    5.04            #peak   313 #SUP  0.95  #QF  0.95 
  9 SER  H      11 ARG  HH21    4.96            #peak   315 #SUP  0.97  #QF  0.97 
  9 SER  H      11 ARG  HH22    5.50            #peak   316 #SUP  0.92  #QF  0.92 
 10 LEU  H      11 ARG  HE      5.50            #peak   318 #SUP  0.99  #QF  0.99 
 10 LEU  H      11 ARG  HH21    5.50            #peak   319 #SUP  0.95  #QF  0.95 
 10 LEU  H      11 ARG  HB3     5.50            #peak   320 #SUP  0.90  #QF  0.59 
 10 LEU  H      12 LYS  QG      5.50            #peak   320 #SUP  0.90  #QF  0.59 
  7 TRP  HB3    11 ARG  H       4.53            #peak   321 #SUP  0.36  #QF  0.36 
  9 SER  H      12 LYS  H       5.50            #peak   323 #SUP  0.98  #QF  0.98 
 11 ARG  HE     12 LYS  H       5.50            #peak   324 #SUP  0.92  #QF  0.92 
 10 LEU  QQD    12 LYS  H       5.42            #peak   326 #SUP  0.97  #QF  0.97 
  9 SER  HA     13 GLY  H       4.90            #peak   327 #SUP  0.82  #QF  0.82 
 13 GLY  H      16 ASP  HB2     5.50            #peak   328 #SUP  0.28  #QF  0.28 
 10 LEU  QQD    13 GLY  H       4.57            #peak   329 #SUP  0.59  #QF  0.59 
 15 TYR  QD     17 GLY  H       5.50            #peak   330 #SUP  0.70  #QF  0.70 
 17 GLY  H      18 GLU  QG      5.06            #peak   331 #SUP  0.99  #QF  0.99 
 16 ASP  HA     18 GLU  H       4.68            #peak   332 #SUP  0.95  #QF  0.95 
 18 GLU  H      21 ARG  HB3     4.58            #peak   334 #SUP  0.57  #QF  0.57 
 14 PHE  QB     19 ALA  H       4.47            #peak   335 #SUP  0.76  #QF  0.76 
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 20 GLY  H      22 ALA  H       3.37            #peak   337 #SUP  0.97  #QF  0.97 
 20 GLY  H      23 ILE  QG2     5.50            #peak   338 #SUP  0.74  #QF  0.74 
 21 ARG  H      24 ARG  H       5.50            #peak   339 #SUP  0.98  #QF  0.98 
 11 ARG  QD     11 ARG  HE      2.80            #peak   340 #SUP  0.99  #QF  0.99 
 18 GLU  HA     21 ARG  HE      5.07            #peak   341 #SUP  0.64  #QF  0.64 
 11 ARG  HA     11 ARG  HE      4.51            #peak   342 #SUP  0.99  #QF  0.99 
 23 ILE  H      23 ILE  HB      2.68            #peak   349 #SUP  0.78  #QF  0.78 
 20 GLY  HA3    24 ARG  H       5.50            #peak   350 #SUP  0.91  #QF  0.91 
 20 GLY  HA2    24 ARG  H       5.35            #peak   351 #SUP  0.91  #QF  0.91 
  2 ALA  H       3 TRP  QB      4.99            #peak   352 #SUP  0.92  #QF  0.92 
 10 LEU  H      10 LEU  QB      2.42            #peak   353 #SUP  0.65  #QF  0.65 
  3 TRP  H       3 TRP  HE1     4.89            #peak   354 #SUP  0.96  #QF  0.96 
  7 TRP  H       7 TRP  HE3     3.43            #peak   357 #SUP  0.67  #QF  0.67 
  7 TRP  H       7 TRP  HB2     2.55            #peak   359 #SUP  0.51  #QF  0.51 
  3 TRP  H       4 LYS  H       2.81            #peak   360 #SUP  0.89  #QF  0.89 
  2 ALA  H       4 LYS  H       4.31            #peak   361 #SUP  0.95  #QF  0.95 
  7 TRP  H      11 ARG  HH21    3.99            #peak   363 #SUP  0.90  #QF  0.90 
  7 TRP  H      11 ARG  HH22    3.81            #peak   364 #SUP  0.75  #QF  0.75 
  3 TRP  HA      4 LYS  H       3.50            #peak   365 #SUP  0.98  #QF  0.98 
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  1 GLY  QA      4 LYS  H       3.99            #peak   368 #SUP  0.79  #QF  0.79 
  4 LYS  H       4 LYS  QE      5.15            #peak   370 #SUP  0.61  #QF  0.61 
  4 LYS  H       4 LYS  QB      2.72            #peak   374 #SUP  0.91  #QF  0.91 
  4 LYS  H       4 LYS  QD      3.67            #peak   375 #SUP  1.00 
  4 LYS  H       4 LYS  HG3     3.54            #peak   376 #SUP  0.98  #QF  0.98 
  4 LYS  H       4 LYS  HG2     3.54            #peak   377 #SUP  0.99  #QF  0.99 
  8 SER  H       9 SER  H       5.50            #peak   381 #SUP  1.00 
  8 SER  H      10 LEU  H       5.50            #peak   382 #SUP  1.00 
  8 SER  H      11 ARG  H       5.50            #peak   382 #SUP  1.00 
  8 SER  H      11 ARG  HE      4.14            #peak   383 #SUP  0.96  #QF  0.96 
  8 SER  H       8 SER  HA      2.85            #peak   384 #SUP  0.97  #QF  0.97 
  7 TRP  HA      8 SER  H       3.45            #peak   386 #SUP  0.99  #QF  0.99 
  7 TRP  HB2     8 SER  H       3.32            #peak   388 #SUP  0.74  #QF  0.74 
  8 SER  H       8 SER  QB      3.21            #peak   389 #SUP  0.96  #QF  0.96 
  8 SER  H      10 LEU  QB      5.50            #peak   390 #SUP  0.77  #QF  0.77 
 15 TYR  H      15 TYR  HA      2.92            #peak   393 #SUP  0.99  #QF  0.99 
 15 TYR  H      15 TYR  HB2     2.90            #peak   394 #SUP  0.89  #QF  0.89 
 15 TYR  H      15 TYR  HB3     2.90            #peak   395 #SUP  0.76  #QF  0.76 
 14 PHE  QD     15 TYR  H       3.28            #peak   398 #SUP  0.49  #QF  0.49 
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 14 PHE  H      14 PHE  QD      3.31            #peak   401 #SUP  0.75  #QF  0.75 
 14 PHE  H      14 PHE  QE      4.37            #peak   402 #SUP  0.95  #QF  0.95 
 12 LYS  H      14 PHE  H       5.50            #peak   405 #SUP  0.99  #QF  0.99 
 15 TYR  H      17 GLY  H       5.50            #peak   406 #SUP  0.70  #QF  0.70 
  3 TRP  HD1     4 LYS  H       5.50            #peak   407 #SUP  0.99  #QF  0.97 
  7 TRP  H       7 TRP  HD1     5.50            #peak   407 #SUP  0.99  #QF  0.97 
  4 LYS  H       5 ASN  HD21    5.50            #peak   408 #SUP  0.90  #QF  0.35 
  7 TRP  H       8 SER  HA      5.50            #peak   409 #SUP  0.97  #QF  0.97 
  8 SER  H      11 ARG  HH22    4.17            #peak   410 #SUP  0.82  #QF  0.82 
  8 SER  H      11 ARG  HH21    3.91            #peak   412 #SUP  0.96  #QF  0.96 
  9 SER  HB3    10 LEU  H       4.00            #peak   413 #SUP  0.90  #QF  0.90 
  8 SER  HA     11 ARG  H       3.40            #peak   414 #SUP  0.42  #QF  0.42 
 23 ILE  H      24 ARG  HG2     4.25            #peak   416 #SUP  0.50  #QF  0.50 
  3 TRP  H       4 LYS  QG      5.34            #peak   298 
  4 LYS  H       4 LYS  QG      3.04            #peak   376 
  4 LYS  QG      5 ASN  H       4.19            #peak   282 
  6 PHE  H       6 PHE  QB      2.50            #peak   133 
  9 SER  H       9 SER  QB      2.58            #peak    49 
  9 SER  H      12 LYS  QD      5.34            #peak   143 
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 12 LYS  H      12 LYS  QD      3.63            #peak   235 
 12 LYS  H      13 GLY  QA      4.12            #peak   107 
 12 LYS  QD     13 GLY  H       3.72            #peak    12 
 13 GLY  QA     16 ASP  H       4.84            #peak   216 
 15 TYR  H      15 TYR  QB      2.35            #peak   395 
 24 ARG  H      24 ARG  QB      3.35            #peak    65 
 25 ARG  H      25 ARG  QB      2.52            #peak   118 
 17 GLY  QA     21 ARG  HA      6.38            #peak 10062 
 24 ARG  HA     24 ARG  HB2     3.00            #peak 10100 
 24 ARG  HA     25 ARG  H       3.00            #peak 10109 
 24 ARG  HA     24 ARG  HB3     3.00            #peak 10111 
 21 ARG  HA     21 ARG  HB2     3.00            #peak 10133 
 21 ARG  HA     21 ARG  HB3     3.00            #peak 10134 
 23 ILE  HA     23 ILE  HB      3.00            #peak 10138 
 17 GLY  QA     18 GLU  QB      6.13            #peak 10278 
 21 ARG  HA     24 ARG  QD      4.03            #peak 10125 
 21 ARG  HA     21 ARG  QG      3.88            #peak 10128 
 21 ARG  HA     21 ARG  HE      4.35            #peak 10129 
 12 LYS  HA     12 LYS  QG      3.88            #peak 10140 
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  3 TRP  QB      3 TRP  HD1     3.88            #peak 10020 
  3 TRP  QB      3 TRP  HE3     3.88            #peak 10335 
 12 LYS  QB     12 LYS  QE      7.06            #peak 10186 
 15 TYR  HA     15 TYR  QE      5.33            #peak 10245 
 11 ARG  HA     15 TYR  QE      7.16            #peak 10247 
 15 TYR  H      15 TYR  QE      6.31            #peak 10288 
 15 TYR  H      15 TYR  QD      5.28            #peak 10316 
 15 TYR  HA     15 TYR  QD      5.38            #peak 10317 
 12 LYS  HA     15 TYR  QD      6.70            #peak 10318 
 10 LEU  HA     15 TYR  QD      7.28            #peak 10319 
  2 ALA  H       2 ALA  QB      4.02            #peak 10077 
 22 ALA  QB     25 ARG  QG      7.40            #peak 10079 
 22 ALA  QB     23 ILE  QG2     7.41            #peak 10082 
 22 ALA  QB     23 ILE  QD1     7.54            #peak 10083 
 23 ILE  HB     23 ILE  QD1     4.02            #peak 10088 
 23 ILE  QG2    24 ARG  HA      5.02            #peak 10114 
 23 ILE  HA     23 ILE  QG2     4.02            #peak 10144 
 23 ILE  HA     23 ILE  QD1     4.02            #peak 10145 
 10 LEU  HA     10 LEU  QQD     5.10            #peak 10158 
 112 
 
 18 GLU  QG     22 ALA  QB      6.93            #peak 10199 
 19 ALA  HA     22 ALA  QB      4.02            #peak 10203 
  2 ALA  QB      3 TRP  HZ3     4.89            #peak 10250 
 10 LEU  QQD    14 PHE  QD      9.73            #peak 10251 
  2 ALA  QB      3 TRP  HE3     4.02            #peak 10343 
  9 SER  QB     10 LEU  H       3.12            #peak 10173 
 11 ARG  QG     11 ARG  QH1     4.01            #peak 10039 
 11 ARG  QH2    15 TYR  QD      4.99            #peak 10232 
 17 GLY  QA     20 GLY  QA      6.16            #peak 10061 
 20 GLY  QA     21 ARG  H       2.74            #peak 10160 
 21 ARG  QB     21 ARG  HE      2.97            #peak 10331 
 21 ARG  QB     22 ALA  QB      6.29            #peak 10081 
 
 
